<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.1?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="iso-abbrev">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="publisher-id">nar</journal-id>
    <journal-title-group>
      <journal-title>Nucleic Acids Research</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">0305-1048</issn>
    <issn pub-type="epub">1362-4962</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">8262697</article-id>
    <article-id pub-id-type="pmid">34060630</article-id>
    <article-id pub-id-type="doi">10.1093/nar/gkab434</article-id>
    <article-id pub-id-type="publisher-id">gkab434</article-id>
    <article-categories>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI00010</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Web Server Issue</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>GPCRsignal: webserver for analysis of the interface between G-protein–coupled receptors and their effector proteins by dynamics and mutations</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Miszta</surname>
          <given-names>Przemysław</given-names>
        </name>
        <xref rid="FN1" ref-type="author-notes"/>
        <aff><institution>Faculty of Chemistry, Biological and Chemical Research Centre, University of Warsaw</institution>, 02-093 Warsaw, <country country="PL">Poland</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Pasznik</surname>
          <given-names>Paweł</given-names>
        </name>
        <xref rid="FN1" ref-type="author-notes"/>
        <aff><institution>Faculty of Chemistry, Biological and Chemical Research Centre, University of Warsaw</institution>, 02-093 Warsaw, <country country="PL">Poland</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Niewieczerzał</surname>
          <given-names>Szymon</given-names>
        </name>
        <aff><institution>Faculty of Chemistry, Biological and Chemical Research Centre, University of Warsaw</institution>, 02-093 Warsaw, <country country="PL">Poland</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Jakowiecki</surname>
          <given-names>Jakub</given-names>
        </name>
        <aff><institution>Faculty of Chemistry, Biological and Chemical Research Centre, University of Warsaw</institution>, 02-093 Warsaw, <country country="PL">Poland</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3147-3858</contrib-id>
        <name>
          <surname>Filipek</surname>
          <given-names>Sławomir</given-names>
        </name>
        <!--sfilipek@chem.uw.edu.pl-->
        <xref rid="COR1" ref-type="corresp"/>
        <aff><institution>Faculty of Chemistry, Biological and Chemical Research Centre, University of Warsaw</institution>, 02-093 Warsaw, <country country="PL">Poland</country></aff>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="COR1">To whom correspondence should be addressed. Tel: +48 22 5526405; Email: <email>sfilipek@chem.uw.edu.pl</email></corresp>
      <fn id="FN1">
        <p>The authors wish it to be known that, in their opinion, the first two authors should be regarded as Joint First Authors.</p>
      </fn>
    </author-notes>
    <pub-date pub-type="collection">
      <day>02</day>
      <month>7</month>
      <year>2021</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2021-06-01">
      <day>01</day>
      <month>6</month>
      <year>2021</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>01</day>
      <month>6</month>
      <year>2021</year>
    </pub-date>
    <volume>49</volume>
    <issue>W1</issue>
    <fpage>W247</fpage>
    <lpage>W256</lpage>
    <history>
      <date date-type="accepted">
        <day>07</day>
        <month>5</month>
        <year>2021</year>
      </date>
      <date date-type="rev-recd">
        <day>20</day>
        <month>4</month>
        <year>2021</year>
      </date>
      <date date-type="received">
        <day>15</day>
        <month>3</month>
        <year>2021</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2021. Published by Oxford University Press on behalf of Nucleic Acids Research.</copyright-statement>
      <copyright-year>2021</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="gkab434.pdf"/>
    <abstract>
      <title>Abstract</title>
      <p>GPCRsignal (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://gpcrsignal.biomodellab.eu/" ext-link-type="uri">https://gpcrsignal.biomodellab.eu/</ext-link>) is a webserver devoted to signaling complexes of G-protein–coupled receptors (GPCRs). The recent improvement in cryo-electron microscopy resulted in the determination of a large number of high-resolution structures of GPCRs bound to their effector proteins: G proteins or arrestins. Analyzing the interfaces between receptor and an effector protein is of high importance since a selection of proper G protein or specific conformation of arrestin leads to changes of signaling that can significantly affect action of drugs. GPCRsignal provides a possibility of running molecular dynamics simulations of all currently available GPCR-effector protein complexes for curated structures: wild-type, with crystal/cryo-EM mutations, or with mutations introduced by the user. The simulations are performed in an implicit water-membrane environment, so they are rather fast. User can run several simulations to obtain statistically valid results. The simulations can be analyzed separately using dynamic FlarePlots for particular types of interactions. One can also compare groups of simulations in Interaction frequency analysis as HeatMaps and also in interaction frequency difference analysis as sticks, linking the interacting residues, of different color and size proportional to differences in contact frequencies.</p>
    </abstract>
    <abstract abstract-type="graphical">
      <title>Graphical Abstract</title>
      <p>
        <fig position="float" id="ga1">
          <label>Graphical Abstract</label>
          <caption>
            <p>The main features of GPCRsignal.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="gkab434gra1" position="float"/>
        </fig>
      </p>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Science Centre</institution>
            <institution-id institution-id-type="DOI">10.13039/501100004281</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>OPUS 2017/25/B/NZ7/02788</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="10"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec sec-type="intro" id="SEC2">
    <title>INTRODUCTION</title>
    <p>G-protein–coupled receptors (GPCRs) constitute the largest family of cell membrane receptors. It comprises of &gt;800 members which mediate majority of physiological functions in human signaling systems such as the nervous, muscular, skeletal, endocrine and digestive systems among others (<xref rid="B1" ref-type="bibr">1</xref>,<xref rid="B2" ref-type="bibr">2</xref>). Since GPCRs are the essential cell membrane signaling molecules and malfunctions of GPCRs cause severe diseases, they represent the most important drug targets—it is estimated that one-third of all currently used drugs are directed toward GPCRs (<xref rid="B3" ref-type="bibr">3</xref>). Structurally, the cores of all GPCRs are very similar: extracellular N-terminus, a bundle of seven transmembrane α-helices (TMs) with extracellular and intracellular loops and intracellular C-terminus. There are several classes of GPCRs differing mostly in size and function of extramembrane domains. According to the GRAFS classification system (<xref rid="B4" ref-type="bibr">4</xref>), the human GPCRs are divided into five families: the rhodopsin-like (class A), secretin (class B1), adhesion (class B2), glutamate (class C) and the frizzled/taste 2 family (class F); however, the newest data (<xref rid="B5" ref-type="bibr">5</xref>) suggest that there are more families (sometimes with only one representative receptor) and that frizzled and taste 2 form separate families. Most receptors (about 700) belong to class A that has a main (orthosteric) ligand-binding pocket between the transmembrane helices.</p>
    <p>GPCRs were long thought as being localized only in the plasma membrane and allowing transmitting of the external signals into the cell interior. It is now recognized that GPCRs signal also at various intracellular locations, and the mechanisms and (patho)physiological relevance of such signaling modes are being actively investigated. Activation of GPCRs is accompanied by the outward movement of the intracellular part of transmembrane helix TM6 and also a smaller movement of helix TM5, which creates a cavity on the cytoplasmic side of the TM domain to bind G protein. Because of large excess of GPCR types over G proteins, it has been thought that every GPCR couples to a specific G protein subfamily; however, there is an experimental evidence that GPCRs can activate G proteins from multiple families. After phosphorylation of the C-terminus of GPCRs by G-protein–coupled receptor kinases (GRKs) arrestin can bind and block G protein coupling, but at the same time it participates in the second route of signaling (<xref rid="B6" ref-type="bibr">6</xref>,<xref rid="B7" ref-type="bibr">7</xref>). A tendency of GPCRs to work through different signaling modes is largely based on the structural plasticity of the receptors themselves and also in complexes with effector proteins (<xref rid="B8" ref-type="bibr">8</xref>). Most ligands of GPCRs can activate both routes of signaling (unbiased ligands), but some ligands preferentially activate only a subset of the signaling pathways (biased ligands) (<xref rid="B9" ref-type="bibr">9</xref>,<xref rid="B10" ref-type="bibr">10</xref>). That is why they have a great potential to become next-generation GPCR drugs with less side effects due to preferable activation of desired signaling pathways (<xref rid="B11" ref-type="bibr">11</xref>). Biased and unbiased signaling are extremely important in pharmacology, and the structures of GPCRs with G proteins and arrestins can help elucidate details of such signaling (<xref rid="B12" ref-type="bibr">12</xref>).</p>
    <p>GPCRs can sense a large number of extracellular stimuli such as neurotransmitters, nucleotides, peptides, small proteins, lipids, as well as photons and ions, and translate that external signal into cellular responses by activating intracellular effector proteins: heterotrimeric G proteins and arrestins. G proteins are organized in four different families (G<sub>s</sub>, G<sub>i/o</sub>, G<sub>q/11</sub> and G<sub>12/13</sub>) and comprise a total of 16 distinct subfamilies based on their Gα subunits (<xref rid="B13" ref-type="bibr">13</xref>). After activation, GPCRs are desensitized through phosphorylation and subsequent binding of β-arrestin, which can lead to receptor internalization. β-Arrestins can act as scaffolds for other proteins such as kinases and phosphodiesterases among others (<xref rid="B10" ref-type="bibr">10</xref>,<xref rid="B14" ref-type="bibr">14</xref>). Moreover, in recent years it has been found that β-arrestin can bind to GPCRs in at least two distinct conformations and the distinct GPCR–arrestin complexes can lead to distinct cellular functions (<xref rid="B15" ref-type="bibr">15–18</xref>). The arrestin family comprises of visual arrestins, β-arrestins and α-arrestins. β-Arrestins belong to a family of multifunctional scaffolding proteins. Functions of α-arrestins are less known than other arrestins, but they can serve as versatile adaptors that link GPCRs or the Notch receptor to E3 ubiquitin ligases and endocytic factors. The α- and β-arrestins could also form transient heterodimers that form a bridge between cargo and E3 ubiquitin ligases for subsequent trafficking (<xref rid="B19" ref-type="bibr">19</xref>).</p>
    <p>Currently, there are about 100 structures of GPCRs determined in a complex with an arrestin or a G protein. The preferable method for structure determination of such complexes is cryo-EM since these complexes can be very large including stabilizing antibodies/nanobodies and lipids surrounding GPCR in a micelle or nanodisc. However, the first structure of GPCR with effector protein was determined by X-ray diffraction of a crystal—it was the β<sub>2</sub>-adrenergic receptor bound to G<sub>s</sub> (<xref rid="B20" ref-type="bibr">20</xref>). In recent years (2019–2020), there has been an increase with over 200% in the number of structures of GPCR complexes with effector proteins and a similar pace is expected. Some unusual structures have also been determined, like the fungal class D receptor dimer coupled to two G proteins (<xref rid="B21" ref-type="bibr">21</xref>). Another example is the structure of the adrenomedullin receptor complex with G protein and with RAMP (receptor activity-modifying protein) (<xref rid="B22" ref-type="bibr">22</xref>). Because of those and other structures, a new service combing the functionality of a curated database and a web server would be highly beneficial to analyze structures of the interfaces of GPCR-effector protein complexes. It is needed to elucidate effects of particular residues on the effector protein selectivity and biased signaling. This can be done by mutation of these residues and analysis of the changes in the interfaces. One can also make simulations of wild-type structures as well as with engineered mutations introduced for structure stabilization.</p>
    <p>There are two web servers offering MD simulations for GPCRs: GPCR-ModSim (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://gpcr-modsim.org/" ext-link-type="uri">http://gpcr-modsim.org/</ext-link>) and Hybrid MM/CG (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://mmcg.grs.kfa-juelich.de/" ext-link-type="uri">https://mmcg.grs.kfa-juelich.de/</ext-link>). The GPCR-ModSim (<xref rid="B23" ref-type="bibr">23</xref>) was created for homology modeling of GPCRs, and the constructed model is equilibrated for 5 ns in explicit all-atom water-membrane environment using a hexagonal periodic box. The POPC (palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine) membrane and the SPC water model are used. The OPLS force field is employed for the protein atoms, while the Berger parameters are used for the membrane. In the Hybrid MM/CG webserver (<xref rid="B24" ref-type="bibr">24</xref>), there is a possibility to run a combined all-atom and coarse-grained MD simulation, up to 10 ns, of GPCR-small ligand complex. The part of the protein with the ligand bound is simulated in all-atom representation in water hemisphere (MM) while the rest of protein in coarse-grained representation (CG). For MM part, the Amber14SB force field is used for protein atoms, TIP3P model for water and GAFF force field for small molecule ligands. The CG region is described by Gö-like potential. In both servers, there is a possibility to introduce mutations by submitting the manually modified GPCR sequence (in Hybrid MM/CG via GOMoDo web server (<xref rid="B25" ref-type="bibr">25</xref>)); however, none of them is dealing with complexes of GPCRs with effector proteins. None of them is also analyzing MD simulations for particular residue–residue interactions (via FlarePlots or HeatMaps). There is also no possibility to compare series of simulations.</p>
    <p>The GPCRsignal allows to run only the curated complexes of GPCRs with effector proteins, so it is also related to databases on GPCRs: GPCRdb (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://gpcrdb.org/" ext-link-type="uri">https://gpcrdb.org/</ext-link>) and GPCRmd (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://submission.gpcrmd.org/home/" ext-link-type="uri">https://submission.gpcrmd.org/home/</ext-link>). The GPCRdb database (<xref rid="B26" ref-type="bibr">26</xref>) is based on the static structures of GPCRs and their complexes with no ability to introduce mutations to the structure and analyzing their dynamic effects. However, GPCRdb has many tools for analysis of mutations and to design mutations for the ligand-binding site (ligand-site mutation design tool), thermostabilizing mutations (construct design tool) and G-protein–coupling altering mutations. The mutation design tools has been updated with the new mutagenesis data and receptor–ligand interactions from structures. The other related great web resource is GPCRmd (<xref rid="B27" ref-type="bibr">27</xref>). That service is a database for analyzing deposited trajectories of all-atom MD simulations performed in explicit membrane and water of curated GPCR–ligand complexes. However, there is no possibility to introduce mutations and running simulations online. The GPCRmd is focused on receptors, so it does not contain complexes of GPCRs with effector proteins.</p>
    <p>The GPCRsignal web server has many features which can be used by a broad range of researchers and students, molecular modelers as well as experimentalists. The service is friendly to be used by unexperienced people and the extensive tutorial explains the procedures and analyses in detail and also provides a graphical introduction to the signaling processes of GPCRs.</p>
  </sec>
  <sec sec-type="materials|methods" id="SEC3">
    <title>MATERIALS AND METHODS</title>
    <sec id="SEC3-1">
      <title>Web interface</title>
      <p>The web interface was created in Bootstrap/jQuery/HTML5 with protein visualization Javascript libraries: Mol* (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://github.com/molstar/molstar" ext-link-type="uri">https://github.com/molstar/molstar</ext-link>) (<xref rid="B28" ref-type="bibr">28</xref>), MolArt (<xref rid="B29" ref-type="bibr">29</xref>), NGL Viewer (<xref rid="B30" ref-type="bibr">30</xref>,<xref rid="B31" ref-type="bibr">31</xref>) and some python visualization tools: Flareplot (time-flare version) (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://gpcrviz.github.io/flareplot/" ext-link-type="uri">https://gpcrviz.github.io/flareplot/</ext-link>), get_contacts (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://getcontacts.github.io/" ext-link-type="uri">https://getcontacts.github.io/</ext-link>) for the Interaction frequency analysis. We used AJAX loading for bigger and on-the-fly computed elements and AJAX updated status of progress bar while computing main job.</p>
    </sec>
    <sec id="SEC3-2">
      <title>Backend of the server</title>
      <p>The server is developed for running one machine with Django framework hosted web interface, maintaining jobs and serve database of complexes and multiple GPGPU servers for running user jobs. Our infrastructure is built on nodes containing two GPUs each, so we decided to run two user jobs per node and share our resources depending on final server usage to minimize waiting time. The server will stay free for all users. The calculations are relatively fast, so one can perform series of MD simulations. Longer MD simulations are also possible but off the web server on the individual basis since the server and underlying methodology are in constant development. Molecular dynamics process is performed in implicit water and membrane environment using IMM1 (<xref rid="B32" ref-type="bibr">32</xref>) method implemented in NAMD v.2.13 (<xref rid="B33" ref-type="bibr">33</xref>) running on CUDA-enabled GPUs server.</p>
    </sec>
    <sec id="SEC3-3">
      <title>Implicit environments calculation</title>
      <p>Molecular dynamics simulations of GPCRs in complexes with effector proteins and peptide ligands are executed in the service based on the all-atom representation of protein structures embedded in the implicit heterogeneous environment representing both solvent and membrane media. The approach is based on the implicit membrane methodology IMM1 (<xref rid="B32" ref-type="bibr">32</xref>) being the extension of EEF1 method (<xref rid="B34" ref-type="bibr">34</xref>). The method is defined only on CHARMM19 polar force field combined with a Gaussian model for the solvation free energy. The implicit solvation term has a form:<disp-formula><tex-math id="M1">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$$\begin{equation*}\Delta {G^{solv}} = \mathop \sum \limits_i \Delta G_i^{solv} = \mathop \sum \limits_i \Delta G_i^{ref} - \mathop \sum \limits_i \mathop \sum \limits_{j \ne i} f_i^{free}\left( {{r_{ij}}} \right){V_j}\end{equation*}$$\end{document}</tex-math></disp-formula>where <inline-formula><tex-math id="M2">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\Delta G_i^{solv}\;$\end{document}</tex-math></inline-formula>is the solvation free energy of atom <italic toggle="yes">i</italic>, and <inline-formula><tex-math id="M3">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}${r_{ij}}$\end{document}</tex-math></inline-formula> is a distance between atoms <italic toggle="yes">i</italic> and <italic toggle="yes">j</italic>, <inline-formula><tex-math id="M4">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\Delta G_i^{ref}$\end{document}</tex-math></inline-formula> is free energy of atom <italic toggle="yes">i</italic> in a small group exposed to solvent, <inline-formula><tex-math id="M5">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\;{V_j}$\end{document}</tex-math></inline-formula> is a volume occupied by atom <italic toggle="yes">j</italic>, and <inline-formula><tex-math id="M6">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$f_i^{free}$\end{document}</tex-math></inline-formula> is the free energy density of atom <italic toggle="yes">i</italic>. The solvation model takes into account how neighboring atoms affect the solvation energy of a given atom (<inline-formula><tex-math id="M7">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\Delta G_i^{ref}$\end{document}</tex-math></inline-formula>) by excluding solvent from the surrounding space. Free energy density has a form of Gaussian function. The membrane is introduced as a slab parallel to <italic toggle="yes">xy</italic> plane centered at <italic toggle="yes">z</italic> = 0. The solvation parameters for each atom are defined for both environments (solvent and the membrane), and they smoothly transit at the interface using the switching function. Figure <xref rid="F1" ref-type="fig">1</xref> shows a scheme of a continuous change of solvation potential in a water-membrane system and also a GPCR simulated in implicit membrane environment.</p>
      <fig position="float" id="F1">
        <label>Figure 1.</label>
        <caption>
          <p>An implicit solvent method IMM1. (<bold>A</bold>) A continuous change of solvation potential in a water-membrane system. (<bold>B</bold>) A GPCR in the implicit membrane environment.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="gkab434fig1" position="float"/>
      </fig>
      <p>The transition region between the hydrophobic core and the solvent environment is about 6 Å wide, which is in agreement with experimental data of lipid bilayers. The electrostatic interactions are modeled by distant dependent dielectric constant. For details of the implicit solvent method, please see the original papers (<xref rid="B32" ref-type="bibr">32</xref>,<xref rid="B34" ref-type="bibr">34</xref>). For simulations, we use Langevin dynamics with damping constant of 40 ps<sup>–1</sup> and with 2 fs time step whereas all bond lengths are constrained using SHAKE (<xref rid="B35" ref-type="bibr">35</xref>) algorithm. The simulations run at temperature 298 K. Originally, the IMM1 method was implemented in CHARMM program (<xref rid="B36" ref-type="bibr">36</xref>); however, herein our implementation of the method in NAMD (<xref rid="B33" ref-type="bibr">33</xref>) is used to facilitate from GPGPU and parallelization. CHARMM19 force field is used since the IMM1 method was parametrized only for this force field. CHARMM19 is a united-atom force field without aliphatic hydrogens, which additionally diminishes number of atoms in the system. CHARMM19 was parametrized only for standard amino acids so to study interactions of arrestins with phosphorylated residues on C-terminus of GPCRs we made parametrization of phosphorylated serine (SEP, ‘s’ in one-letter code for flareplots and mutations) and threonine (TPO, ‘t’ in one-letter code for flareplots and mutations). Because of lack of parametrization of small molecules in CHARMM19, all ligands except the peptide ones had to be removed from calculations (such information has been placed in MD&amp;mut page close to ‘Start MD’ button); however, because of short length of simulations such influence is negligible. We plan to upgrade to all-atom CHARMM36 force field where there are parameters for small ligands to use in explicit environments. New parameters, specific for implicit environments, for small ligands and also for amino acids, will be developed and validated.</p>
    </sec>
    <sec id="SEC3-4">
      <title>Curation process of structures</title>
      <p>During curation process all antibodies/nanobodies and fusion proteins were removed. Nonpeptide ligands were also removed due to usage of CHARMM19 force field. The peptide ligands and also some additional proteins, like the receptor activity-modifying protein (Figure <xref rid="F2" ref-type="fig">2A</xref>,B), are kept and included in simulations. In case of dimeric structures (currently, there is one such structure PDB ID:7AD3), all dimers are kept. Since one of G proteins is not visible in that experimental structure we made a model of a full dimeric complex which is available with a new accession name, 7AD3m. This dimeric complex is also available for mutations and simulations.</p>
      <fig position="float" id="F2">
        <label>Figure 2.</label>
        <caption>
          <p>(<bold>A</bold>) Structure of selected PDB ID: 6UVA complex in Mol* viewer. One can also see it in MolArt viewer. (<bold>B</bold>) One of tiles describing details of the complex. (<bold>C</bold>) MD&amp;mutation preparation page filled with data from example input (CB<sub>1</sub> cannabinoid receptor PDB ID: 6KPG).</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="gkab434fig2" position="float"/>
      </fig>
      <p>Single residues lacking a certain number of atoms were rebuilt; however, the lacking ranges of residues in loops and also in N- and C-termini were not restored. The ends of lacking fragments were left uncharged during preparation of input structures for simulations. The missing fragments in experimental structures will be reconstructed in the next version of the web server. The smaller fragments will be wholly rebuilt while the larger fragments will be substituted with smaller ones. However, this should be done with caution. Two lists of complexes will be available: without modifications and with missing fragments restored. Reconstruction of part of receptor’s C-terminus is also regarded as it was found important for G protein binding and especially for arrestin binding (in this case with phosphorylated residues). For each complex in our service two structures were prepared: the structure with engineered mutations and wild-type (WT) structure. The user defined mutations, also to and from phosphorylated serine ‘s’ and threonine ‘t’, are introduced to WT structure and the simulation is started.</p>
    </sec>
    <sec id="SEC3-5">
      <title>Contact network analysis</title>
      <p>GetContacts software is used for analysis of the interface interactions between the receptor and the effector protein. Flareplot (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://gpcrviz.github.io/flareplot/" ext-link-type="uri">https://gpcrviz.github.io/flareplot/</ext-link>) is used to visualize the interface interactions occurring in a user-selected timeframe of the trajectory. In our web server, using get_dynamic_contacts.py tool, we create a list of all residue–residue contacts between the receptor and the effector protein occurring in each frame of the MD trajectory. Next, using get_contact_frequencies.py module, we calculate the frequency of each interaction found in the contact list file. The interaction frequency (Freq) ranges between 0 and 1: Freq = 1.0 means that a particular interaction is present in every single trajectory frame, Freq = 0.5 means the interaction is found only in 50% of the frames, while Freq = 0 means the interaction does not occur in the analyzed trajectory.</p>
      <p>In order to identify those contacts for which the frequency differs significantly between the two selected groups of simulations, we calculate the difference between average frequencies of a particular contact (Δ<italic toggle="yes"><sub>freq</sub></italic>, described by equation below):<disp-formula><tex-math id="M8">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$$\begin{equation*}{\Delta _{{\rm freq}}} = \overline {Fre{q_{{\rm group}\;1}}} {\rm{\;}} - {\rm{\;}}\overline {Fre{q_{{\rm group}\;2}}} \end{equation*}$$\end{document}</tex-math></disp-formula></p>
      <p>If the absolute value of the difference between the average frequencies of a particular contact calculated for the two sets of trajectories is higher than a specific cut-off value, then the contact is kept as a potentially meaningful (e.g. if cutoff is set to 0.4, then only the contacts with |Δ<italic toggle="yes"><sub>freq</sub></italic>| &gt; 0.4 are kept). We visualize the average frequency differences for these meaningful interactions as red and blue sticks linking C<sub>α</sub> atoms of the interacting residues.</p>
    </sec>
    <sec id="SEC3-6">
      <title>Workflow</title>
      <p>We have created user-job pipeline with four steps and additional calculations on-the-fly while loading page or selecting elements by user. On-the-fly mode applies to initial loading of Interaction frequency analysis (HeatMaps) and to the Interaction frequency difference analysis (Sticks). By changing the contact type (hydrogen bonds, salt bridges and aromatic interactions) and/or cutoffs for HeatMaps and Sticks they are recalculated and user can check status messages (computing/done/error). Server is importing data from internal GPCRsignal database, such as PDB and PSF files, membrane thickness, and chain identifiers for receptor and each effector protein.</p>
      <p>The steps are:</p>
      <list list-type="order">
        <list-item>
          <p>Preparation phase—applying mutations to WT structure and preparing NAMD input files.</p>
        </list-item>
        <list-item>
          <p>Molecular dynamics—running all-atom MD simulation in implicit environments.</p>
        </list-item>
        <list-item>
          <p>Plotting—running get_contacts scripts (computing for displaying results and pre-computing as much as possible for on-the-fly computations).</p>
        </list-item>
        <list-item>
          <p>Finishing – creating archives, copying working files to results directory, sending e-mail with job status.</p>
        </list-item>
      </list>
    </sec>
  </sec>
  <sec sec-type="results" id="SEC4">
    <title>RESULTS</title>
    <sec id="SEC4-1">
      <title>Description of input</title>
      <p>User can browse through a table of curated structures of GPCR-effector protein (G protein or arrestin) complexes. After selecting a structure, the user can go into details of the complex presenting structure and descriptions on several tiles (Figure <xref rid="F2" ref-type="fig">2A</xref>,B) or go to the MD&amp;mutation preparation page (Figure <xref rid="F2" ref-type="fig">2C</xref>).</p>
      <p>In the MD&amp;mutation page the Mutations mode (Figure <xref rid="F2" ref-type="fig">2C</xref>) has to be selected: (i) with crystal/cryo-EM structure mutations, (ii) WT or (iii) WT with user defined mutations. There is no maximal number of user mutations. Then, parameters of simulations are to be specified or their default values used: (i) total length of a simulation: default = 10 ns, min = 5 ns, max = 25 ns; (ii) number of frames in a simulation: default = 100, min = 5, max = 200; and (iii) the membrane thickness: default value is taken from internal database (based on value for particular receptor in OPM database (<xref rid="B37" ref-type="bibr">37</xref>) ), min = 20 Å, max = 40 Å. All the above selections must be confirmed by the user after pushing ‘Start MD’ button. On the confirmation page, there is also a possibility to add a job description and e-mail for receiving notification of job completion.</p>
    </sec>
    <sec id="SEC4-2">
      <title>Description of output</title>
      <p>After completion of the MD simulation a new page starts with analysis of single trajectory. On that page one can select type of contact, e.g. hydrogen bonds, and the FlarePlot can visualize contacts in the interface between receptor and effector protein for the single frame (Figure <xref rid="F3" ref-type="fig">3A</xref>), range of frames (Figure <xref rid="F3" ref-type="fig">3B</xref>). The structure of the complex (Figure <xref rid="F3" ref-type="fig">3C</xref>) is changing as the simulation is playing and it refers to a particular frame or the first frame if a range of frames is selected. A variety of options for displaying a structure are available (Figure <xref rid="F3" ref-type="fig">3D</xref>).</p>
      <fig position="float" id="F3">
        <label>Figure 3.</label>
        <caption>
          <p>Analysis of a single trajectory. (<bold>A</bold>) FlarePlot showing contacts in the interface between receptor (purple color) and effector protein (G<sub>α</sub>—green, G<sub>β</sub>—yellow, G<sub>γ</sub>—orange) for the single frame. (<bold>B</bold>) The same for range of frames. (<bold>C</bold>) The structure of the complex with blue and red transparent squares visualizing the edges of the membrane. (<bold>D</bold>) The menu for displaying a complex structure. The color mode GPCRsignal is the same as shown in panel (C).</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="gkab434fig3" position="float"/>
      </fig>
      <p>Analysis of multiple MDs starts from selecting of completed simulations by copying their tokens into a table on ‘Comparison of multiple MDs’ page. The computed trajectories are stored on the server for two months. Comparison of trajectories can be done via Interaction frequency analysis on HeatMaps (Figure <xref rid="F4" ref-type="fig">4A</xref>) and via the Interaction frequency difference analysis (Figure <xref rid="F4" ref-type="fig">4B</xref>). In both cases, the specific cutoffs can be set up to exclude the smallest contact frequencies. For the latter analysis, the interaction frequency difference is visualized via sticks linking interacting residues (their C<sub>α</sub> atoms) with blue and red color meaning positive or negative difference in contact frequencies. Since the simulations start each time with different set of atom velocities the final structures and resulting contacts can be different even for the same initial complex structure as this is a statistical process. Therefore, a series of shorter simulations with later averaging is preferred over one longer simulation.</p>
      <fig position="float" id="F4">
        <label>Figure 4.</label>
        <caption>
          <p>(<bold>A</bold>) Interaction frequency analysis on HeatMaps. A scale bar shows percentage of frequencies. A cutoff excludes the smallest contact frequencies. The first two simulations are for WT, while two others for mutated structure. (<bold>B</bold>) Interaction frequency difference analysis for selected two groups of simulations denoted A and B. Here, group A is for WT simulations and B for simulations with mutated structure. The sticks linking C<sub>α</sub> atoms of interacting residues are colored in red and blue meaning positive or negative difference in contact frequencies, respectively. The size of sticks and color intensity are proportional to particular contact frequency difference and is visualized on a scale hourglass. As before, the cutoff excludes the smallest differences in contact frequencies.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="gkab434fig4" position="float"/>
      </fig>
      <p>One can download a package with results for each task. It is a ZIP file including basic files: protein structure (format PDB/PSF), result of molecular dynamics (format DCD), job information file (text file), contacts files (format: tab-separated values) and Flareplot files (format json). Protein files are ready to use with corresponding DCD file if user want to visualize simulation in external visualization software. Protein results files depend on selected wild-type or crystal/cryo-EM structure mode, and include user applied mutations if they were used. From the job information file, one can take the job parameters or take a link to results to visualize those results on GPCRsignal server and make analyses (if within 2 months).</p>
      <p>For the contacts, we supply file describing all contacts between receptor and effector proteins in simulation, and type-separated contact frequencies files. Flareplots could be generated by uploading those json files on the page: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://gpcrviz.github.io/flareplot/?p=create" ext-link-type="uri">https://gpcrviz.github.io/flareplot/?p=create</ext-link>. It is useful when one needs to display results after 2 months (when data will be removed from our server) or when user want to make any changes to circular plot.</p>
      <p>There is a possibility to share the selected MD simulations with other users. This can be done with a button ‘Make this job available to public’ on the results page (accessible just after the simulation is completed or later with the simulation token). The shared simulations are visible via menu item ‘Shared jobs’. The shared data can be analyzed as single trajectories or groups of simulations via ‘Comparison’ page.</p>
    </sec>
    <sec id="SEC4-3">
      <title>Performance and comparison to all-atom explicit system</title>
      <p>MD simulation of 25 ns for CB<sub>1</sub> receptor with trimeric G protein (PDB ID: 6KPG), with number of atoms and united atoms in CHARMM19 force field about 8700, takes about 6 h. For comparison, 25 ns MD simulation of the same system in full POPC membrane and water, containing about 120 000 atoms, takes about 120 h (5 days) on the same server.</p>
      <p>We compared RMSD (root-mean-square deviation) plots for exemplary complex PDB ID: 6KPG simulated in explicit (EE) and implicit (IE) environments (Figure <xref rid="F5" ref-type="fig">5</xref>). RMSD values were calculated for C<sub>α</sub> atoms of the whole complex. For the WT complex simulated in EE the structure stabilized at 2 Å in one MD simulation but at 3 Å in the second simulation (Figure <xref rid="F5" ref-type="fig">5A</xref>) while it reached 4 and 4.5 Å in IE (Figure <xref rid="F5" ref-type="fig">5B</xref>). For the mutated complex simulated in EE, the structure stabilized at about 2.5 Å in both simulations (Figure <xref rid="F6" ref-type="fig">6A</xref>) and in IE at 4 Å (Figure <xref rid="F6" ref-type="fig">6B</xref>). For the mutated structure, we selected a set of disruptive mutations: R:R145A, R:R226A, A:D350A and A:F354A, where the first letter denotes a chain: R for receptor and A for G<sub>α</sub> subunit. Such mutations disrupted salt bridges and stacking interactions but MD simulations conducted both in EE and IE show that the overall structure of the complex is still very stable. Local changes can be visualized using FlarePlots and HeatMaps in our server. Higher values of RMSD plots obtained in IE are a consequence of higher flexibility of the complex in implicit environments. Length of 25 ns of MD simulation seems to be adequate to obtain stability of complex structure, however, to compare the immediate effects of mutations much smaller MD simulations can be applied.</p>
      <fig position="float" id="F5">
        <label>Figure 5.</label>
        <caption>
          <p>RMSD plots for the same exemplary wild-type (WT) CB<sub>1</sub>-G<sub>i(αβγ)</sub> complex (PDB id:6KPG) simulated in explicit (<bold>A</bold>) and implicit (<bold>B</bold>) environments.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="gkab434fig5" position="float"/>
      </fig>
      <fig position="float" id="F6">
        <label>Figure 6.</label>
        <caption>
          <p>RMSD plots for the same exemplary CB<sub>1</sub>-G<sub>i(αβγ)</sub> complex (PDB ID: 6KPG) with four user defined mutations (4 mut) simulated in explicit (<bold>A</bold>) and implicit (<bold>B</bold>) environments.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="gkab434fig6" position="float"/>
      </fig>
    </sec>
    <sec id="SEC4-4">
      <title>Tutorial</title>
      <p>The extensive tutorial starts from a slide show showing the GPCR signaling cycle which could be useful for students and also researchers not working routinely with GPCRs. Then, each page of the web server is described with all available options. The example output is also shown for analysis of single MD simulation (menu: Example 1) and for analysis of multiple MD simulations (menu: Example 2). All types of performed analyses are described and especially those for groups of simulations: the interaction frequency analysis (HeatMaps) and the interaction frequency difference analysis (Sticks).</p>
    </sec>
  </sec>
  <sec sec-type="conclusions" id="SEC5">
    <title>CONCLUSION</title>
    <p>The GPCRsignal web server is intended to be used for analyses of the interface between GPCRs and their effector proteins: G proteins and arrestins. The analyses are performed in a dynamic way by MD simulations and mutations and they can be useful for researchers and students interested in GPCR signaling processes. Currently, there are about 100 structures of GPCR-effector protein complexes in the Protein Data Bank but due to enormous progress in experimental determination of such complexes we can expect a large number of such structures which will greatly facilitate research on biased signaling.</p>
  </sec>
  <sec sec-type="data-availability" id="SEC6">
    <title>DATA AVAILABILITY</title>
    <p>GPCRsignal is free to all users without a login requirement. The e-mail is optional (for receiving notification of job completion) and is not stored on the server.</p>
  </sec>
</body>
<back>
  <ack id="ACK1">
    <title>ACKNOWLEDGEMENTS</title>
    <p>The European COST Action CA18133 (ERNEST) is acknowledged for providing biannual forum for exchange of ideas on GPCR research and for supporting mutual visits.</p>
  </ack>
  <sec id="SEC7">
    <title>FUNDING</title>
    <p>National Science Centre [OPUS 2017/25/B/NZ7/02788 to S.F.]. Funding for open access charge: National Science Centre [OPUS 2017/25/B/NZ7/02788 to S.F.].</p>
    <p><italic toggle="yes">Conflict of interest statement</italic>. None declared.</p>
  </sec>
  <ref-list id="REF1">
    <title>REFERENCES</title>
    <ref id="B1">
      <label>1.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rockman</surname><given-names>H.A.</given-names></string-name>, <string-name><surname>Koch</surname><given-names>W.J.</given-names></string-name>, <string-name><surname>Lefkowitz</surname><given-names>R.J.</given-names></string-name></person-group><article-title>Seven-transmembrane-spanning receptors and heart function</article-title>. <source>Nature</source>. <year>2002</year>; <volume>415</volume>:<fpage>206</fpage>–<lpage>212</lpage>.<pub-id pub-id-type="pmid">11805844</pub-id></mixed-citation>
    </ref>
    <ref id="B2">
      <label>2.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hilger</surname><given-names>D.</given-names></string-name>, <string-name><surname>Masureel</surname><given-names>M.</given-names></string-name>, <string-name><surname>Kobilka</surname><given-names>B.K.</given-names></string-name></person-group><article-title>Structure and dynamics of GPCR signaling complexes</article-title>. <source>Nat. Struct. Mol. Biol.</source><year>2018</year>; <volume>25</volume>:<fpage>4</fpage>–<lpage>12</lpage>.<pub-id pub-id-type="pmid">29323277</pub-id></mixed-citation>
    </ref>
    <ref id="B3">
      <label>3.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hauser</surname><given-names>A.S.</given-names></string-name>, <string-name><surname>Attwood</surname><given-names>M.M.</given-names></string-name>, <string-name><surname>Rask-Andersen</surname><given-names>M.</given-names></string-name>, <string-name><surname>Schioth</surname><given-names>H.B.</given-names></string-name>, <string-name><surname>Gloriam</surname><given-names>D.E.</given-names></string-name></person-group><article-title>Trends in GPCR drug discovery: new agents, targets and indications</article-title>. <source>Nat. Rev. Drug Discov.</source><year>2017</year>; <volume>16</volume>:<fpage>829</fpage>–<lpage>842</lpage>.<pub-id pub-id-type="pmid">29075003</pub-id></mixed-citation>
    </ref>
    <ref id="B4">
      <label>4.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fredriksson</surname><given-names>R.</given-names></string-name>, <string-name><surname>Lagerstrom</surname><given-names>M.C.</given-names></string-name>, <string-name><surname>Lundin</surname><given-names>L.G.</given-names></string-name>, <string-name><surname>Schioth</surname><given-names>H.B.</given-names></string-name></person-group><article-title>The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints</article-title>. <source>Mol. Pharmacol.</source><year>2003</year>; <volume>63</volume>:<fpage>1256</fpage>–<lpage>1272</lpage>.<pub-id pub-id-type="pmid">12761335</pub-id></mixed-citation>
    </ref>
    <ref id="B5">
      <label>5.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nordstrom</surname><given-names>K.J.</given-names></string-name>, <string-name><surname>Sallman Almen</surname><given-names>M.</given-names></string-name>, <string-name><surname>Edstam</surname><given-names>M.M.</given-names></string-name>, <string-name><surname>Fredriksson</surname><given-names>R.</given-names></string-name>, <string-name><surname>Schioth</surname><given-names>H.B.</given-names></string-name></person-group><article-title>Independent HHsearch, Needleman–Wunsch-based, and motif analyses reveal the overall hierarchy for most of the G protein-coupled receptor families</article-title>. <source>Mol. Biol. Evol.</source><year>2011</year>; <volume>28</volume>:<fpage>2471</fpage>–<lpage>2480</lpage>.<pub-id pub-id-type="pmid">21402729</pub-id></mixed-citation>
    </ref>
    <ref id="B6">
      <label>6.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gurevich</surname><given-names>V.V.</given-names></string-name>, <string-name><surname>Gurevich</surname><given-names>E.V.</given-names></string-name></person-group><article-title>GPCR signaling regulation: the role of GRKs and arrestins</article-title>. <source>Front. Pharmacol.</source><year>2019</year>; <volume>10</volume>:<fpage>125</fpage>.<pub-id pub-id-type="pmid">30837883</pub-id></mixed-citation>
    </ref>
    <ref id="B7">
      <label>7.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Seyedabadi</surname><given-names>M.</given-names></string-name>, <string-name><surname>Gharghabi</surname><given-names>M.</given-names></string-name>, <string-name><surname>Gurevich</surname><given-names>E.V.</given-names></string-name>, <string-name><surname>Gurevich</surname><given-names>V.V.</given-names></string-name></person-group><article-title>Receptor-arrestin interactions: the GPCR perspective</article-title>. <source>Biomolecules</source>. <year>2021</year>; <volume>11</volume>:<fpage>218</fpage>.<pub-id pub-id-type="pmid">33557162</pub-id></mixed-citation>
    </ref>
    <ref id="B8">
      <label>8.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sutkeviciute</surname><given-names>I.</given-names></string-name>, <string-name><surname>Vilardaga</surname><given-names>J.P.</given-names></string-name></person-group><article-title>Structural insights into emergent signaling modes of G protein-coupled receptors</article-title>. <source>J. Biol. Chem.</source><year>2020</year>; <volume>295</volume>:<fpage>11626</fpage>–<lpage>11642</lpage>.<pub-id pub-id-type="pmid">32571882</pub-id></mixed-citation>
    </ref>
    <ref id="B9">
      <label>9.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kenakin</surname><given-names>T.</given-names></string-name></person-group><article-title>Biased receptor signaling in drug discovery</article-title>. <source>Pharmacol. Rev.</source><year>2019</year>; <volume>71</volume>:<fpage>267</fpage>–<lpage>315</lpage>.<pub-id pub-id-type="pmid">30914442</pub-id></mixed-citation>
    </ref>
    <ref id="B10">
      <label>10.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Smith</surname><given-names>J.S.</given-names></string-name>, <string-name><surname>Lefkowitz</surname><given-names>R.J.</given-names></string-name>, <string-name><surname>Rajagopal</surname><given-names>S.</given-names></string-name></person-group><article-title>Biased signalling: from simple switches to allosteric microprocessors</article-title>. <source>Nat. Rev. Drug Discov.</source><year>2018</year>; <volume>17</volume>:<fpage>243</fpage>–<lpage>260</lpage>.<pub-id pub-id-type="pmid">29302067</pub-id></mixed-citation>
    </ref>
    <ref id="B11">
      <label>11.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bock</surname><given-names>A.</given-names></string-name>, <string-name><surname>Bermudez</surname><given-names>M.</given-names></string-name></person-group><article-title>Allosteric coupling and biased agonism in G protein-coupled receptors</article-title>. <source>FEBS J.</source><year>2021</year>; <volume>288</volume>:<fpage>2513</fpage>–<lpage>2528</lpage>.<pub-id pub-id-type="pmid">33621418</pub-id></mixed-citation>
    </ref>
    <ref id="B12">
      <label>12.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Erlandson</surname><given-names>S.C.</given-names></string-name>, <string-name><surname>McMahon</surname><given-names>C.</given-names></string-name>, <string-name><surname>Kruse</surname><given-names>A.C.</given-names></string-name></person-group><article-title>Structural basis for G protein-coupled receptor signaling</article-title>. <source>Annu. Rev. Biophys.</source><year>2018</year>; <volume>47</volume>:<fpage>1</fpage>–<lpage>18</lpage>.<pub-id pub-id-type="pmid">29498889</pub-id></mixed-citation>
    </ref>
    <ref id="B13">
      <label>13.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Milligan</surname><given-names>G.</given-names></string-name>, <string-name><surname>Kostenis</surname><given-names>E.</given-names></string-name></person-group><article-title>Heterotrimeric G-proteins: a short history</article-title>. <source>Br. J. Pharmacol.</source><year>2006</year>; <volume>147</volume>(<issue>Suppl. 1</issue>):<fpage>S46</fpage>–<lpage>S55</lpage>.<pub-id pub-id-type="pmid">16402120</pub-id></mixed-citation>
    </ref>
    <ref id="B14">
      <label>14.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lefkowitz</surname><given-names>R.J.</given-names></string-name>, <string-name><surname>Shenoy</surname><given-names>S.K.</given-names></string-name></person-group><article-title>Transduction of receptor signals by beta-arrestins</article-title>. <source>Science</source>. <year>2005</year>; <volume>308</volume>:<fpage>512</fpage>–<lpage>517</lpage>.<pub-id pub-id-type="pmid">15845844</pub-id></mixed-citation>
    </ref>
    <ref id="B15">
      <label>15.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shukla</surname><given-names>A.K.</given-names></string-name>, <string-name><surname>Westfield</surname><given-names>G.H.</given-names></string-name>, <string-name><surname>Xiao</surname><given-names>K.</given-names></string-name>, <string-name><surname>Reis</surname><given-names>R.I.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>L.Y.</given-names></string-name>, <string-name><surname>Tripathi-Shukla</surname><given-names>P.</given-names></string-name>, <string-name><surname>Qian</surname><given-names>J.</given-names></string-name>, <string-name><surname>Li</surname><given-names>S.</given-names></string-name>, <string-name><surname>Blanc</surname><given-names>A.</given-names></string-name>, <string-name><surname>Oleskie</surname><given-names>A.N.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Visualization of arrestin recruitment by a G-protein-coupled receptor</article-title>. <source>Nature</source>. <year>2014</year>; <volume>512</volume>:<fpage>218</fpage>–<lpage>222</lpage>.<pub-id pub-id-type="pmid">25043026</pub-id></mixed-citation>
    </ref>
    <ref id="B16">
      <label>16.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Latorraca</surname><given-names>N.R.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>J.K.</given-names></string-name>, <string-name><surname>Bauer</surname><given-names>B.</given-names></string-name>, <string-name><surname>Townshend</surname><given-names>R.J.L.</given-names></string-name>, <string-name><surname>Hollingsworth</surname><given-names>S.A.</given-names></string-name>, <string-name><surname>Olivieri</surname><given-names>J.E.</given-names></string-name>, <string-name><surname>Xu</surname><given-names>H.E.</given-names></string-name>, <string-name><surname>Sommer</surname><given-names>M.E.</given-names></string-name>, <string-name><surname>Dror</surname><given-names>R.O</given-names></string-name></person-group><article-title>Molecular mechanism of GPCR-mediated arrestin activation</article-title>. <source>Nature</source>. <year>2018</year>; <volume>557</volume>:<fpage>452</fpage>–<lpage>456</lpage>.<pub-id pub-id-type="pmid">29720655</pub-id></mixed-citation>
    </ref>
    <ref id="B17">
      <label>17.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cahill</surname><given-names>T.J.</given-names><suffix>3rd</suffix></string-name>, <string-name><surname>Thomsen</surname><given-names>A.R.</given-names></string-name>, <string-name><surname>Tarrasch</surname><given-names>J.T.</given-names></string-name>, <string-name><surname>Plouffe</surname><given-names>B.</given-names></string-name>, <string-name><surname>Nguyen</surname><given-names>A.H.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>F.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>L.Y.</given-names></string-name>, <string-name><surname>Kahsai</surname><given-names>A.W.</given-names></string-name>, <string-name><surname>Bassoni</surname><given-names>D.L.</given-names></string-name>, <string-name><surname>Gavino</surname><given-names>B.J.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Distinct conformations of GPCR-beta-arrestin complexes mediate desensitization, signaling, and endocytosis</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source><year>2017</year>; <volume>114</volume>:<fpage>2562</fpage>–<lpage>2567</lpage>.<pub-id pub-id-type="pmid">28223524</pub-id></mixed-citation>
    </ref>
    <ref id="B18">
      <label>18.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Latorraca</surname><given-names>N.R.</given-names></string-name>, <string-name><surname>Masureel</surname><given-names>M.</given-names></string-name>, <string-name><surname>Hollingsworth</surname><given-names>S.A.</given-names></string-name>, <string-name><surname>Heydenreich</surname><given-names>F.M.</given-names></string-name>, <string-name><surname>Suomivuori</surname><given-names>C.M.</given-names></string-name>, <string-name><surname>Brinton</surname><given-names>C.</given-names></string-name>, <string-name><surname>Townshend</surname><given-names>R.J.L.</given-names></string-name>, <string-name><surname>Bouvier</surname><given-names>M.</given-names></string-name>, <string-name><surname>Kobilka</surname><given-names>B.K.</given-names></string-name>, <string-name><surname>Dror</surname><given-names>R.O</given-names></string-name></person-group><article-title>How GPCR phosphorylation patterns orchestrate arrestin-mediated signaling</article-title>. <source>Cell</source>. <year>2020</year>; <volume>183</volume>:<fpage>1813</fpage>–<lpage>1825</lpage>.<pub-id pub-id-type="pmid">33296703</pub-id></mixed-citation>
    </ref>
    <ref id="B19">
      <label>19.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Puca</surname><given-names>L.</given-names></string-name>, <string-name><surname>Brou</surname><given-names>C.</given-names></string-name></person-group><article-title>Alpha-arrestins - new players in Notch and GPCR signaling pathways in mammals</article-title>. <source>J. Cell Sci.</source><year>2014</year>; <volume>127</volume>:<fpage>1359</fpage>–<lpage>1367</lpage>.<pub-id pub-id-type="pmid">24687185</pub-id></mixed-citation>
    </ref>
    <ref id="B20">
      <label>20.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cherezov</surname><given-names>V.</given-names></string-name>, <string-name><surname>Rosenbaum</surname><given-names>D.M.</given-names></string-name>, <string-name><surname>Hanson</surname><given-names>M.A.</given-names></string-name>, <string-name><surname>Rasmussen</surname><given-names>S.G.</given-names></string-name>, <string-name><surname>Thian</surname><given-names>F.S.</given-names></string-name>, <string-name><surname>Kobilka</surname><given-names>T.S.</given-names></string-name>, <string-name><surname>Choi</surname><given-names>H.J.</given-names></string-name>, <string-name><surname>Kuhn</surname><given-names>P.</given-names></string-name>, <string-name><surname>Weis</surname><given-names>W.I.</given-names></string-name>, <string-name><surname>Kobilka</surname><given-names>B.K.</given-names></string-name><etal>et al</etal>.</person-group><article-title>High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor</article-title>. <source>Science</source>. <year>2007</year>; <volume>318</volume>:<fpage>1258</fpage>–<lpage>1265</lpage>.<pub-id pub-id-type="pmid">17962520</pub-id></mixed-citation>
    </ref>
    <ref id="B21">
      <label>21.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Velazhahan</surname><given-names>V.</given-names></string-name>, <string-name><surname>Ma</surname><given-names>N.</given-names></string-name>, <string-name><surname>Pandy-Szekeres</surname><given-names>G.</given-names></string-name>, <string-name><surname>Kooistra</surname><given-names>A.J.</given-names></string-name>, <string-name><surname>Lee</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Gloriam</surname><given-names>D.E.</given-names></string-name>, <string-name><surname>Vaidehi</surname><given-names>N.</given-names></string-name>, <string-name><surname>Tate</surname><given-names>C.G.</given-names></string-name></person-group><article-title>Structure of the class D GPCR Ste2 dimer coupled to two G proteins</article-title>. <source>Nature</source>. <year>2021</year>; <volume>589</volume>:<fpage>148</fpage>–<lpage>153</lpage>.<pub-id pub-id-type="pmid">33268889</pub-id></mixed-citation>
    </ref>
    <ref id="B22">
      <label>22.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liang</surname><given-names>Y.L.</given-names></string-name>, <string-name><surname>Belousoff</surname><given-names>M.J.</given-names></string-name>, <string-name><surname>Fletcher</surname><given-names>M.M.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>X.</given-names></string-name>, <string-name><surname>Khoshouei</surname><given-names>M.</given-names></string-name>, <string-name><surname>Deganutti</surname><given-names>G.</given-names></string-name>, <string-name><surname>Koole</surname><given-names>C.</given-names></string-name>, <string-name><surname>Furness</surname><given-names>S.G.B.</given-names></string-name>, <string-name><surname>Miller</surname><given-names>L.J.</given-names></string-name>, <string-name><surname>Hay</surname><given-names>D.L.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Structure and dynamics of adrenomedullin receptors AM1 and AM2 reveal key mechanisms in the control of receptor phenotype by receptor activity-modifying proteins</article-title>. <source>ACS Pharmacol. Transl. Sci.</source><year>2020</year>; <volume>3</volume>:<fpage>263</fpage>–<lpage>284</lpage>.<pub-id pub-id-type="pmid">32296767</pub-id></mixed-citation>
    </ref>
    <ref id="B23">
      <label>23.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Esguerra</surname><given-names>M.</given-names></string-name>, <string-name><surname>Siretskiy</surname><given-names>A.</given-names></string-name>, <string-name><surname>Bello</surname><given-names>X.</given-names></string-name>, <string-name><surname>Sallander</surname><given-names>J.</given-names></string-name>, <string-name><surname>Gutierrez-de-Teran</surname><given-names>H.</given-names></string-name></person-group><article-title>GPCR-ModSim: a comprehensive web based solution for modeling G-protein coupled receptors</article-title>. <source>Nucleic Acids Res.</source><year>2016</year>; <volume>44</volume>:<fpage>W455</fpage>–<lpage>W462</lpage>.<pub-id pub-id-type="pmid">27166369</pub-id></mixed-citation>
    </ref>
    <ref id="B24">
      <label>24.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schneider</surname><given-names>J.</given-names></string-name>, <string-name><surname>Ribeiro</surname><given-names>R.</given-names></string-name>, <string-name><surname>Alfonso-Prieto</surname><given-names>M.</given-names></string-name>, <string-name><surname>Carloni</surname><given-names>P.</given-names></string-name>, <string-name><surname>Giorgetti</surname><given-names>A.</given-names></string-name></person-group><article-title>Hybrid MM/CG webserver: automatic set up of molecular mechanics/coarse-grained simulations for human G protein-coupled receptor/ligand complexes</article-title>. <source>Front. Mol. Biosci.</source><year>2020</year>; <volume>7</volume>:<fpage>576689</fpage>.<pub-id pub-id-type="pmid">33102525</pub-id></mixed-citation>
    </ref>
    <ref id="B25">
      <label>25.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sandal</surname><given-names>M.</given-names></string-name>, <string-name><surname>Duy</surname><given-names>T.P.</given-names></string-name>, <string-name><surname>Cona</surname><given-names>M.</given-names></string-name>, <string-name><surname>Zung</surname><given-names>H.</given-names></string-name>, <string-name><surname>Carloni</surname><given-names>P.</given-names></string-name>, <string-name><surname>Musiani</surname><given-names>F.</given-names></string-name>, <string-name><surname>Giorgetti</surname><given-names>A.</given-names></string-name></person-group><article-title>GOMoDo: a GPCRs online modeling and docking webserver</article-title>. <source>PLoS One</source>. <year>2013</year>; <volume>8</volume>:<fpage>e74092</fpage>.<pub-id pub-id-type="pmid">24058518</pub-id></mixed-citation>
    </ref>
    <ref id="B26">
      <label>26.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kooistra</surname><given-names>A.J.</given-names></string-name>, <string-name><surname>Mordalski</surname><given-names>S.</given-names></string-name>, <string-name><surname>Pandy-Szekeres</surname><given-names>G.</given-names></string-name>, <string-name><surname>Esguerra</surname><given-names>M.</given-names></string-name>, <string-name><surname>Mamyrbekov</surname><given-names>A.</given-names></string-name>, <string-name><surname>Munk</surname><given-names>C.</given-names></string-name>, <string-name><surname>Keseru</surname><given-names>G.M.</given-names></string-name>, <string-name><surname>Gloriam</surname><given-names>D.E.</given-names></string-name></person-group><article-title>GPCRdb in 2021: integrating GPCR sequence, structure and function</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>; <volume>49</volume>:<fpage>D335</fpage>–<lpage>D343</lpage>.<pub-id pub-id-type="pmid">33270898</pub-id></mixed-citation>
    </ref>
    <ref id="B27">
      <label>27.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rodriguez-Espigares</surname><given-names>I.</given-names></string-name>, <string-name><surname>Torrens-Fontanals</surname><given-names>M.</given-names></string-name>, <string-name><surname>Tiemann</surname><given-names>J.K.S.</given-names></string-name>, <string-name><surname>Aranda-Garcia</surname><given-names>D.</given-names></string-name>, <string-name><surname>Ramirez-Anguita</surname><given-names>J.M.</given-names></string-name>, <string-name><surname>Stepniewski</surname><given-names>T.M.</given-names></string-name>, <string-name><surname>Worp</surname><given-names>N.</given-names></string-name>, <string-name><surname>Varela-Rial</surname><given-names>A.</given-names></string-name>, <string-name><surname>Morales-Pastor</surname><given-names>A.</given-names></string-name>, <string-name><surname>Medel-Lacruz</surname><given-names>B.</given-names></string-name><etal>et al</etal>.</person-group><article-title>GPCRmd uncovers the dynamics of the 3D-GPCRome</article-title>. <source>Nat. Methods</source>. <year>2020</year>; <volume>17</volume>:<fpage>777</fpage>–<lpage>787</lpage>.<pub-id pub-id-type="pmid">32661425</pub-id></mixed-citation>
    </ref>
    <ref id="B28">
      <label>28.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sehnal</surname><given-names>D.</given-names></string-name>, <string-name><surname>Bittrich</surname><given-names>S.</given-names></string-name>, <string-name><surname>Deshpande</surname><given-names>M.</given-names></string-name>, <string-name><surname>Svobodova</surname><given-names>R.</given-names></string-name>, <string-name><surname>Berka</surname><given-names>K.</given-names></string-name>, <string-name><surname>Bazgier</surname><given-names>V.</given-names></string-name>, <string-name><surname>Velankar</surname><given-names>S.</given-names></string-name>, <string-name><surname>Burley</surname><given-names>S.K.</given-names></string-name>, <string-name><surname>Koca</surname><given-names>J.</given-names></string-name>, <string-name><surname>Rose</surname><given-names>A.S.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Mol* Viewer: modern web app for 3D visualization and analysis of large biomolecular structures</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>; <pub-id pub-id-type="doi">10.1093/nar/gkab314</pub-id>.</mixed-citation>
    </ref>
    <ref id="B29">
      <label>29.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hoksza</surname><given-names>D.</given-names></string-name>, <string-name><surname>Gawron</surname><given-names>P.</given-names></string-name>, <string-name><surname>Ostaszewski</surname><given-names>M.</given-names></string-name>, <string-name><surname>Schneider</surname><given-names>R.</given-names></string-name></person-group><article-title>MolArt: a molecular structure annotation and visualization tool</article-title>. <source>Bioinformatics</source>. <year>2018</year>; <volume>34</volume>:<fpage>4127</fpage>–<lpage>4128</lpage>.<pub-id pub-id-type="pmid">29931246</pub-id></mixed-citation>
    </ref>
    <ref id="B30">
      <label>30.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rose</surname><given-names>A.S.</given-names></string-name>, <string-name><surname>Hildebrand</surname><given-names>P.W.</given-names></string-name></person-group><article-title>NGL Viewer: a web application for molecular visualization</article-title>. <source>Nucleic Acids Res.</source><year>2015</year>; <volume>43</volume>:<fpage>W576</fpage>–<lpage>W579</lpage>.<pub-id pub-id-type="pmid">25925569</pub-id></mixed-citation>
    </ref>
    <ref id="B31">
      <label>31.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rose</surname><given-names>A.S.</given-names></string-name>, <string-name><surname>Bradley</surname><given-names>A.R.</given-names></string-name>, <string-name><surname>Valasatava</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Duarte</surname><given-names>J.M.</given-names></string-name>, <string-name><surname>Prlic</surname><given-names>A.</given-names></string-name>, <string-name><surname>Rose</surname><given-names>P.W.</given-names></string-name></person-group><article-title>NGL viewer: web-based molecular graphics for large complexes</article-title>. <source>Bioinformatics</source>. <year>2018</year>; <volume>34</volume>:<fpage>3755</fpage>–<lpage>3758</lpage>.<pub-id pub-id-type="pmid">29850778</pub-id></mixed-citation>
    </ref>
    <ref id="B32">
      <label>32.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lazaridis</surname><given-names>T.</given-names></string-name></person-group><article-title>Effective energy function for proteins in lipid membranes</article-title>. <source>Proteins</source>. <year>2003</year>; <volume>52</volume>:<fpage>176</fpage>–<lpage>192</lpage>.<pub-id pub-id-type="pmid">12833542</pub-id></mixed-citation>
    </ref>
    <ref id="B33">
      <label>33.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Phillips</surname><given-names>J.C.</given-names></string-name>, <string-name><surname>Hardy</surname><given-names>D.J.</given-names></string-name>, <string-name><surname>Maia</surname><given-names>J.D.C.</given-names></string-name>, <string-name><surname>Stone</surname><given-names>J.E.</given-names></string-name>, <string-name><surname>Ribeiro</surname><given-names>J.V.</given-names></string-name>, <string-name><surname>Bernardi</surname><given-names>R.C.</given-names></string-name>, <string-name><surname>Buch</surname><given-names>R.</given-names></string-name>, <string-name><surname>Fiorin</surname><given-names>G.</given-names></string-name>, <string-name><surname>Henin</surname><given-names>J.</given-names></string-name>, <string-name><surname>Jiang</surname><given-names>W.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Scalable molecular dynamics on CPU and GPU architectures with NAMD</article-title>. <source>J. Chem. Phys.</source><year>2020</year>; <volume>153</volume>:<fpage>044130</fpage>.<pub-id pub-id-type="pmid">32752662</pub-id></mixed-citation>
    </ref>
    <ref id="B34">
      <label>34.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lazaridis</surname><given-names>T.</given-names></string-name>, <string-name><surname>Karplus</surname><given-names>M.</given-names></string-name></person-group><article-title>Effective energy function for proteins in solution</article-title>. <source>Proteins</source>. <year>1999</year>; <volume>35</volume>:<fpage>133</fpage>–<lpage>152</lpage>.<pub-id pub-id-type="pmid">10223287</pub-id></mixed-citation>
    </ref>
    <ref id="B35">
      <label>35.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ryckaert</surname><given-names>J.-P.C.</given-names></string-name>, <string-name><surname>Berendsen</surname><given-names>H.J.C</given-names></string-name></person-group><article-title>Numerical integration of the cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes</article-title>. <source>J. Comput. Phys.</source><year>1977</year>; <volume>23</volume>:<fpage>327</fpage>–<lpage>341</lpage>.</mixed-citation>
    </ref>
    <ref id="B36">
      <label>36.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Brooks</surname><given-names>B.R.</given-names></string-name>, <string-name><surname>Brooks</surname><given-names>C.L.</given-names><suffix>3rd</suffix></string-name>, <string-name><surname>Mackerell</surname><given-names>A.D.</given-names><suffix>Jr</suffix></string-name>, <string-name><surname>Nilsson</surname><given-names>L.</given-names></string-name>, <string-name><surname>Petrella</surname><given-names>R.J.</given-names></string-name>, <string-name><surname>Roux</surname><given-names>B.</given-names></string-name>, <string-name><surname>Won</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Archontis</surname><given-names>G.</given-names></string-name>, <string-name><surname>Bartels</surname><given-names>C.</given-names></string-name>, <string-name><surname>Boresch</surname><given-names>S.</given-names></string-name><etal>et al</etal>.</person-group><article-title>CHARMM: the biomolecular simulation program</article-title>. <source>J. Comput. Chem.</source><year>2009</year>; <volume>30</volume>:<fpage>1545</fpage>–<lpage>1614</lpage>.<pub-id pub-id-type="pmid">19444816</pub-id></mixed-citation>
    </ref>
    <ref id="B37">
      <label>37.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lomize</surname><given-names>M.A.</given-names></string-name>, <string-name><surname>Pogozheva</surname><given-names>I.D.</given-names></string-name>, <string-name><surname>Joo</surname><given-names>H.</given-names></string-name>, <string-name><surname>Mosberg</surname><given-names>H.I.</given-names></string-name>, <string-name><surname>Lomize</surname><given-names>A.L.</given-names></string-name></person-group><article-title>OPM database and PPM web server: resources for positioning of proteins in membranes</article-title>. <source>Nucleic Acids Res.</source><year>2012</year>; <volume>40</volume>:<fpage>D370</fpage>–<lpage>D376</lpage>.<pub-id pub-id-type="pmid">21890895</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.1?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="iso-abbrev">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="publisher-id">nar</journal-id>
    <journal-title-group>
      <journal-title>Nucleic Acids Research</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">0305-1048</issn>
    <issn pub-type="epub">1362-4962</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">8262697</article-id>
    <article-id pub-id-type="pmid">34060630</article-id>
    <article-id pub-id-type="doi">10.1093/nar/gkab434</article-id>
    <article-id pub-id-type="publisher-id">gkab434</article-id>
    <article-categories>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI00010</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Web Server Issue</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>GPCRsignal: webserver for analysis of the interface between G-protein–coupled receptors and their effector proteins by dynamics and mutations</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Miszta</surname>
          <given-names>Przemysław</given-names>
        </name>
        <xref rid="FN1" ref-type="author-notes"/>
        <aff><institution>Faculty of Chemistry, Biological and Chemical Research Centre, University of Warsaw</institution>, 02-093 Warsaw, <country country="PL">Poland</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Pasznik</surname>
          <given-names>Paweł</given-names>
        </name>
        <xref rid="FN1" ref-type="author-notes"/>
        <aff><institution>Faculty of Chemistry, Biological and Chemical Research Centre, University of Warsaw</institution>, 02-093 Warsaw, <country country="PL">Poland</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Niewieczerzał</surname>
          <given-names>Szymon</given-names>
        </name>
        <aff><institution>Faculty of Chemistry, Biological and Chemical Research Centre, University of Warsaw</institution>, 02-093 Warsaw, <country country="PL">Poland</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Jakowiecki</surname>
          <given-names>Jakub</given-names>
        </name>
        <aff><institution>Faculty of Chemistry, Biological and Chemical Research Centre, University of Warsaw</institution>, 02-093 Warsaw, <country country="PL">Poland</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3147-3858</contrib-id>
        <name>
          <surname>Filipek</surname>
          <given-names>Sławomir</given-names>
        </name>
        <!--sfilipek@chem.uw.edu.pl-->
        <xref rid="COR1" ref-type="corresp"/>
        <aff><institution>Faculty of Chemistry, Biological and Chemical Research Centre, University of Warsaw</institution>, 02-093 Warsaw, <country country="PL">Poland</country></aff>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="COR1">To whom correspondence should be addressed. Tel: +48 22 5526405; Email: <email>sfilipek@chem.uw.edu.pl</email></corresp>
      <fn id="FN1">
        <p>The authors wish it to be known that, in their opinion, the first two authors should be regarded as Joint First Authors.</p>
      </fn>
    </author-notes>
    <pub-date pub-type="collection">
      <day>02</day>
      <month>7</month>
      <year>2021</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2021-06-01">
      <day>01</day>
      <month>6</month>
      <year>2021</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>01</day>
      <month>6</month>
      <year>2021</year>
    </pub-date>
    <volume>49</volume>
    <issue>W1</issue>
    <fpage>W247</fpage>
    <lpage>W256</lpage>
    <history>
      <date date-type="accepted">
        <day>07</day>
        <month>5</month>
        <year>2021</year>
      </date>
      <date date-type="rev-recd">
        <day>20</day>
        <month>4</month>
        <year>2021</year>
      </date>
      <date date-type="received">
        <day>15</day>
        <month>3</month>
        <year>2021</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2021. Published by Oxford University Press on behalf of Nucleic Acids Research.</copyright-statement>
      <copyright-year>2021</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
      </license>
    </permissions>
    <self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="gkab434.pdf"/>
    <abstract>
      <title>Abstract</title>
      <p>GPCRsignal (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://gpcrsignal.biomodellab.eu/" ext-link-type="uri">https://gpcrsignal.biomodellab.eu/</ext-link>) is a webserver devoted to signaling complexes of G-protein–coupled receptors (GPCRs). The recent improvement in cryo-electron microscopy resulted in the determination of a large number of high-resolution structures of GPCRs bound to their effector proteins: G proteins or arrestins. Analyzing the interfaces between receptor and an effector protein is of high importance since a selection of proper G protein or specific conformation of arrestin leads to changes of signaling that can significantly affect action of drugs. GPCRsignal provides a possibility of running molecular dynamics simulations of all currently available GPCR-effector protein complexes for curated structures: wild-type, with crystal/cryo-EM mutations, or with mutations introduced by the user. The simulations are performed in an implicit water-membrane environment, so they are rather fast. User can run several simulations to obtain statistically valid results. The simulations can be analyzed separately using dynamic FlarePlots for particular types of interactions. One can also compare groups of simulations in Interaction frequency analysis as HeatMaps and also in interaction frequency difference analysis as sticks, linking the interacting residues, of different color and size proportional to differences in contact frequencies.</p>
    </abstract>
    <abstract abstract-type="graphical">
      <title>Graphical Abstract</title>
      <p>
        <fig position="float" id="ga1">
          <label>Graphical Abstract</label>
          <caption>
            <p>The main features of GPCRsignal.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="gkab434gra1" position="float"/>
        </fig>
      </p>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Science Centre</institution>
            <institution-id institution-id-type="DOI">10.13039/501100004281</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>OPUS 2017/25/B/NZ7/02788</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="10"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec sec-type="intro" id="SEC2">
    <title>INTRODUCTION</title>
    <p>G-protein–coupled receptors (GPCRs) constitute the largest family of cell membrane receptors. It comprises of &gt;800 members which mediate majority of physiological functions in human signaling systems such as the nervous, muscular, skeletal, endocrine and digestive systems among others (<xref rid="B1" ref-type="bibr">1</xref>,<xref rid="B2" ref-type="bibr">2</xref>). Since GPCRs are the essential cell membrane signaling molecules and malfunctions of GPCRs cause severe diseases, they represent the most important drug targets—it is estimated that one-third of all currently used drugs are directed toward GPCRs (<xref rid="B3" ref-type="bibr">3</xref>). Structurally, the cores of all GPCRs are very similar: extracellular N-terminus, a bundle of seven transmembrane α-helices (TMs) with extracellular and intracellular loops and intracellular C-terminus. There are several classes of GPCRs differing mostly in size and function of extramembrane domains. According to the GRAFS classification system (<xref rid="B4" ref-type="bibr">4</xref>), the human GPCRs are divided into five families: the rhodopsin-like (class A), secretin (class B1), adhesion (class B2), glutamate (class C) and the frizzled/taste 2 family (class F); however, the newest data (<xref rid="B5" ref-type="bibr">5</xref>) suggest that there are more families (sometimes with only one representative receptor) and that frizzled and taste 2 form separate families. Most receptors (about 700) belong to class A that has a main (orthosteric) ligand-binding pocket between the transmembrane helices.</p>
    <p>GPCRs were long thought as being localized only in the plasma membrane and allowing transmitting of the external signals into the cell interior. It is now recognized that GPCRs signal also at various intracellular locations, and the mechanisms and (patho)physiological relevance of such signaling modes are being actively investigated. Activation of GPCRs is accompanied by the outward movement of the intracellular part of transmembrane helix TM6 and also a smaller movement of helix TM5, which creates a cavity on the cytoplasmic side of the TM domain to bind G protein. Because of large excess of GPCR types over G proteins, it has been thought that every GPCR couples to a specific G protein subfamily; however, there is an experimental evidence that GPCRs can activate G proteins from multiple families. After phosphorylation of the C-terminus of GPCRs by G-protein–coupled receptor kinases (GRKs) arrestin can bind and block G protein coupling, but at the same time it participates in the second route of signaling (<xref rid="B6" ref-type="bibr">6</xref>,<xref rid="B7" ref-type="bibr">7</xref>). A tendency of GPCRs to work through different signaling modes is largely based on the structural plasticity of the receptors themselves and also in complexes with effector proteins (<xref rid="B8" ref-type="bibr">8</xref>). Most ligands of GPCRs can activate both routes of signaling (unbiased ligands), but some ligands preferentially activate only a subset of the signaling pathways (biased ligands) (<xref rid="B9" ref-type="bibr">9</xref>,<xref rid="B10" ref-type="bibr">10</xref>). That is why they have a great potential to become next-generation GPCR drugs with less side effects due to preferable activation of desired signaling pathways (<xref rid="B11" ref-type="bibr">11</xref>). Biased and unbiased signaling are extremely important in pharmacology, and the structures of GPCRs with G proteins and arrestins can help elucidate details of such signaling (<xref rid="B12" ref-type="bibr">12</xref>).</p>
    <p>GPCRs can sense a large number of extracellular stimuli such as neurotransmitters, nucleotides, peptides, small proteins, lipids, as well as photons and ions, and translate that external signal into cellular responses by activating intracellular effector proteins: heterotrimeric G proteins and arrestins. G proteins are organized in four different families (G<sub>s</sub>, G<sub>i/o</sub>, G<sub>q/11</sub> and G<sub>12/13</sub>) and comprise a total of 16 distinct subfamilies based on their Gα subunits (<xref rid="B13" ref-type="bibr">13</xref>). After activation, GPCRs are desensitized through phosphorylation and subsequent binding of β-arrestin, which can lead to receptor internalization. β-Arrestins can act as scaffolds for other proteins such as kinases and phosphodiesterases among others (<xref rid="B10" ref-type="bibr">10</xref>,<xref rid="B14" ref-type="bibr">14</xref>). Moreover, in recent years it has been found that β-arrestin can bind to GPCRs in at least two distinct conformations and the distinct GPCR–arrestin complexes can lead to distinct cellular functions (<xref rid="B15" ref-type="bibr">15–18</xref>). The arrestin family comprises of visual arrestins, β-arrestins and α-arrestins. β-Arrestins belong to a family of multifunctional scaffolding proteins. Functions of α-arrestins are less known than other arrestins, but they can serve as versatile adaptors that link GPCRs or the Notch receptor to E3 ubiquitin ligases and endocytic factors. The α- and β-arrestins could also form transient heterodimers that form a bridge between cargo and E3 ubiquitin ligases for subsequent trafficking (<xref rid="B19" ref-type="bibr">19</xref>).</p>
    <p>Currently, there are about 100 structures of GPCRs determined in a complex with an arrestin or a G protein. The preferable method for structure determination of such complexes is cryo-EM since these complexes can be very large including stabilizing antibodies/nanobodies and lipids surrounding GPCR in a micelle or nanodisc. However, the first structure of GPCR with effector protein was determined by X-ray diffraction of a crystal—it was the β<sub>2</sub>-adrenergic receptor bound to G<sub>s</sub> (<xref rid="B20" ref-type="bibr">20</xref>). In recent years (2019–2020), there has been an increase with over 200% in the number of structures of GPCR complexes with effector proteins and a similar pace is expected. Some unusual structures have also been determined, like the fungal class D receptor dimer coupled to two G proteins (<xref rid="B21" ref-type="bibr">21</xref>). Another example is the structure of the adrenomedullin receptor complex with G protein and with RAMP (receptor activity-modifying protein) (<xref rid="B22" ref-type="bibr">22</xref>). Because of those and other structures, a new service combing the functionality of a curated database and a web server would be highly beneficial to analyze structures of the interfaces of GPCR-effector protein complexes. It is needed to elucidate effects of particular residues on the effector protein selectivity and biased signaling. This can be done by mutation of these residues and analysis of the changes in the interfaces. One can also make simulations of wild-type structures as well as with engineered mutations introduced for structure stabilization.</p>
    <p>There are two web servers offering MD simulations for GPCRs: GPCR-ModSim (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://gpcr-modsim.org/" ext-link-type="uri">http://gpcr-modsim.org/</ext-link>) and Hybrid MM/CG (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://mmcg.grs.kfa-juelich.de/" ext-link-type="uri">https://mmcg.grs.kfa-juelich.de/</ext-link>). The GPCR-ModSim (<xref rid="B23" ref-type="bibr">23</xref>) was created for homology modeling of GPCRs, and the constructed model is equilibrated for 5 ns in explicit all-atom water-membrane environment using a hexagonal periodic box. The POPC (palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine) membrane and the SPC water model are used. The OPLS force field is employed for the protein atoms, while the Berger parameters are used for the membrane. In the Hybrid MM/CG webserver (<xref rid="B24" ref-type="bibr">24</xref>), there is a possibility to run a combined all-atom and coarse-grained MD simulation, up to 10 ns, of GPCR-small ligand complex. The part of the protein with the ligand bound is simulated in all-atom representation in water hemisphere (MM) while the rest of protein in coarse-grained representation (CG). For MM part, the Amber14SB force field is used for protein atoms, TIP3P model for water and GAFF force field for small molecule ligands. The CG region is described by Gö-like potential. In both servers, there is a possibility to introduce mutations by submitting the manually modified GPCR sequence (in Hybrid MM/CG via GOMoDo web server (<xref rid="B25" ref-type="bibr">25</xref>)); however, none of them is dealing with complexes of GPCRs with effector proteins. None of them is also analyzing MD simulations for particular residue–residue interactions (via FlarePlots or HeatMaps). There is also no possibility to compare series of simulations.</p>
    <p>The GPCRsignal allows to run only the curated complexes of GPCRs with effector proteins, so it is also related to databases on GPCRs: GPCRdb (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://gpcrdb.org/" ext-link-type="uri">https://gpcrdb.org/</ext-link>) and GPCRmd (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://submission.gpcrmd.org/home/" ext-link-type="uri">https://submission.gpcrmd.org/home/</ext-link>). The GPCRdb database (<xref rid="B26" ref-type="bibr">26</xref>) is based on the static structures of GPCRs and their complexes with no ability to introduce mutations to the structure and analyzing their dynamic effects. However, GPCRdb has many tools for analysis of mutations and to design mutations for the ligand-binding site (ligand-site mutation design tool), thermostabilizing mutations (construct design tool) and G-protein–coupling altering mutations. The mutation design tools has been updated with the new mutagenesis data and receptor–ligand interactions from structures. The other related great web resource is GPCRmd (<xref rid="B27" ref-type="bibr">27</xref>). That service is a database for analyzing deposited trajectories of all-atom MD simulations performed in explicit membrane and water of curated GPCR–ligand complexes. However, there is no possibility to introduce mutations and running simulations online. The GPCRmd is focused on receptors, so it does not contain complexes of GPCRs with effector proteins.</p>
    <p>The GPCRsignal web server has many features which can be used by a broad range of researchers and students, molecular modelers as well as experimentalists. The service is friendly to be used by unexperienced people and the extensive tutorial explains the procedures and analyses in detail and also provides a graphical introduction to the signaling processes of GPCRs.</p>
  </sec>
  <sec sec-type="materials|methods" id="SEC3">
    <title>MATERIALS AND METHODS</title>
    <sec id="SEC3-1">
      <title>Web interface</title>
      <p>The web interface was created in Bootstrap/jQuery/HTML5 with protein visualization Javascript libraries: Mol* (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://github.com/molstar/molstar" ext-link-type="uri">https://github.com/molstar/molstar</ext-link>) (<xref rid="B28" ref-type="bibr">28</xref>), MolArt (<xref rid="B29" ref-type="bibr">29</xref>), NGL Viewer (<xref rid="B30" ref-type="bibr">30</xref>,<xref rid="B31" ref-type="bibr">31</xref>) and some python visualization tools: Flareplot (time-flare version) (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://gpcrviz.github.io/flareplot/" ext-link-type="uri">https://gpcrviz.github.io/flareplot/</ext-link>), get_contacts (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://getcontacts.github.io/" ext-link-type="uri">https://getcontacts.github.io/</ext-link>) for the Interaction frequency analysis. We used AJAX loading for bigger and on-the-fly computed elements and AJAX updated status of progress bar while computing main job.</p>
    </sec>
    <sec id="SEC3-2">
      <title>Backend of the server</title>
      <p>The server is developed for running one machine with Django framework hosted web interface, maintaining jobs and serve database of complexes and multiple GPGPU servers for running user jobs. Our infrastructure is built on nodes containing two GPUs each, so we decided to run two user jobs per node and share our resources depending on final server usage to minimize waiting time. The server will stay free for all users. The calculations are relatively fast, so one can perform series of MD simulations. Longer MD simulations are also possible but off the web server on the individual basis since the server and underlying methodology are in constant development. Molecular dynamics process is performed in implicit water and membrane environment using IMM1 (<xref rid="B32" ref-type="bibr">32</xref>) method implemented in NAMD v.2.13 (<xref rid="B33" ref-type="bibr">33</xref>) running on CUDA-enabled GPUs server.</p>
    </sec>
    <sec id="SEC3-3">
      <title>Implicit environments calculation</title>
      <p>Molecular dynamics simulations of GPCRs in complexes with effector proteins and peptide ligands are executed in the service based on the all-atom representation of protein structures embedded in the implicit heterogeneous environment representing both solvent and membrane media. The approach is based on the implicit membrane methodology IMM1 (<xref rid="B32" ref-type="bibr">32</xref>) being the extension of EEF1 method (<xref rid="B34" ref-type="bibr">34</xref>). The method is defined only on CHARMM19 polar force field combined with a Gaussian model for the solvation free energy. The implicit solvation term has a form:<disp-formula><tex-math id="M1">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$$\begin{equation*}\Delta {G^{solv}} = \mathop \sum \limits_i \Delta G_i^{solv} = \mathop \sum \limits_i \Delta G_i^{ref} - \mathop \sum \limits_i \mathop \sum \limits_{j \ne i} f_i^{free}\left( {{r_{ij}}} \right){V_j}\end{equation*}$$\end{document}</tex-math></disp-formula>where <inline-formula><tex-math id="M2">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\Delta G_i^{solv}\;$\end{document}</tex-math></inline-formula>is the solvation free energy of atom <italic toggle="yes">i</italic>, and <inline-formula><tex-math id="M3">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}${r_{ij}}$\end{document}</tex-math></inline-formula> is a distance between atoms <italic toggle="yes">i</italic> and <italic toggle="yes">j</italic>, <inline-formula><tex-math id="M4">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\Delta G_i^{ref}$\end{document}</tex-math></inline-formula> is free energy of atom <italic toggle="yes">i</italic> in a small group exposed to solvent, <inline-formula><tex-math id="M5">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\;{V_j}$\end{document}</tex-math></inline-formula> is a volume occupied by atom <italic toggle="yes">j</italic>, and <inline-formula><tex-math id="M6">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$f_i^{free}$\end{document}</tex-math></inline-formula> is the free energy density of atom <italic toggle="yes">i</italic>. The solvation model takes into account how neighboring atoms affect the solvation energy of a given atom (<inline-formula><tex-math id="M7">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$\Delta G_i^{ref}$\end{document}</tex-math></inline-formula>) by excluding solvent from the surrounding space. Free energy density has a form of Gaussian function. The membrane is introduced as a slab parallel to <italic toggle="yes">xy</italic> plane centered at <italic toggle="yes">z</italic> = 0. The solvation parameters for each atom are defined for both environments (solvent and the membrane), and they smoothly transit at the interface using the switching function. Figure <xref rid="F1" ref-type="fig">1</xref> shows a scheme of a continuous change of solvation potential in a water-membrane system and also a GPCR simulated in implicit membrane environment.</p>
      <fig position="float" id="F1">
        <label>Figure 1.</label>
        <caption>
          <p>An implicit solvent method IMM1. (<bold>A</bold>) A continuous change of solvation potential in a water-membrane system. (<bold>B</bold>) A GPCR in the implicit membrane environment.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="gkab434fig1" position="float"/>
      </fig>
      <p>The transition region between the hydrophobic core and the solvent environment is about 6 Å wide, which is in agreement with experimental data of lipid bilayers. The electrostatic interactions are modeled by distant dependent dielectric constant. For details of the implicit solvent method, please see the original papers (<xref rid="B32" ref-type="bibr">32</xref>,<xref rid="B34" ref-type="bibr">34</xref>). For simulations, we use Langevin dynamics with damping constant of 40 ps<sup>–1</sup> and with 2 fs time step whereas all bond lengths are constrained using SHAKE (<xref rid="B35" ref-type="bibr">35</xref>) algorithm. The simulations run at temperature 298 K. Originally, the IMM1 method was implemented in CHARMM program (<xref rid="B36" ref-type="bibr">36</xref>); however, herein our implementation of the method in NAMD (<xref rid="B33" ref-type="bibr">33</xref>) is used to facilitate from GPGPU and parallelization. CHARMM19 force field is used since the IMM1 method was parametrized only for this force field. CHARMM19 is a united-atom force field without aliphatic hydrogens, which additionally diminishes number of atoms in the system. CHARMM19 was parametrized only for standard amino acids so to study interactions of arrestins with phosphorylated residues on C-terminus of GPCRs we made parametrization of phosphorylated serine (SEP, ‘s’ in one-letter code for flareplots and mutations) and threonine (TPO, ‘t’ in one-letter code for flareplots and mutations). Because of lack of parametrization of small molecules in CHARMM19, all ligands except the peptide ones had to be removed from calculations (such information has been placed in MD&amp;mut page close to ‘Start MD’ button); however, because of short length of simulations such influence is negligible. We plan to upgrade to all-atom CHARMM36 force field where there are parameters for small ligands to use in explicit environments. New parameters, specific for implicit environments, for small ligands and also for amino acids, will be developed and validated.</p>
    </sec>
    <sec id="SEC3-4">
      <title>Curation process of structures</title>
      <p>During curation process all antibodies/nanobodies and fusion proteins were removed. Nonpeptide ligands were also removed due to usage of CHARMM19 force field. The peptide ligands and also some additional proteins, like the receptor activity-modifying protein (Figure <xref rid="F2" ref-type="fig">2A</xref>,B), are kept and included in simulations. In case of dimeric structures (currently, there is one such structure PDB ID:7AD3), all dimers are kept. Since one of G proteins is not visible in that experimental structure we made a model of a full dimeric complex which is available with a new accession name, 7AD3m. This dimeric complex is also available for mutations and simulations.</p>
      <fig position="float" id="F2">
        <label>Figure 2.</label>
        <caption>
          <p>(<bold>A</bold>) Structure of selected PDB ID: 6UVA complex in Mol* viewer. One can also see it in MolArt viewer. (<bold>B</bold>) One of tiles describing details of the complex. (<bold>C</bold>) MD&amp;mutation preparation page filled with data from example input (CB<sub>1</sub> cannabinoid receptor PDB ID: 6KPG).</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="gkab434fig2" position="float"/>
      </fig>
      <p>Single residues lacking a certain number of atoms were rebuilt; however, the lacking ranges of residues in loops and also in N- and C-termini were not restored. The ends of lacking fragments were left uncharged during preparation of input structures for simulations. The missing fragments in experimental structures will be reconstructed in the next version of the web server. The smaller fragments will be wholly rebuilt while the larger fragments will be substituted with smaller ones. However, this should be done with caution. Two lists of complexes will be available: without modifications and with missing fragments restored. Reconstruction of part of receptor’s C-terminus is also regarded as it was found important for G protein binding and especially for arrestin binding (in this case with phosphorylated residues). For each complex in our service two structures were prepared: the structure with engineered mutations and wild-type (WT) structure. The user defined mutations, also to and from phosphorylated serine ‘s’ and threonine ‘t’, are introduced to WT structure and the simulation is started.</p>
    </sec>
    <sec id="SEC3-5">
      <title>Contact network analysis</title>
      <p>GetContacts software is used for analysis of the interface interactions between the receptor and the effector protein. Flareplot (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://gpcrviz.github.io/flareplot/" ext-link-type="uri">https://gpcrviz.github.io/flareplot/</ext-link>) is used to visualize the interface interactions occurring in a user-selected timeframe of the trajectory. In our web server, using get_dynamic_contacts.py tool, we create a list of all residue–residue contacts between the receptor and the effector protein occurring in each frame of the MD trajectory. Next, using get_contact_frequencies.py module, we calculate the frequency of each interaction found in the contact list file. The interaction frequency (Freq) ranges between 0 and 1: Freq = 1.0 means that a particular interaction is present in every single trajectory frame, Freq = 0.5 means the interaction is found only in 50% of the frames, while Freq = 0 means the interaction does not occur in the analyzed trajectory.</p>
      <p>In order to identify those contacts for which the frequency differs significantly between the two selected groups of simulations, we calculate the difference between average frequencies of a particular contact (Δ<italic toggle="yes"><sub>freq</sub></italic>, described by equation below):<disp-formula><tex-math id="M8">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage{upgreek}
\usepackage{mathrsfs}
\setlength{\oddsidemargin}{-69pt}
\begin{document}
}{}$$\begin{equation*}{\Delta _{{\rm freq}}} = \overline {Fre{q_{{\rm group}\;1}}} {\rm{\;}} - {\rm{\;}}\overline {Fre{q_{{\rm group}\;2}}} \end{equation*}$$\end{document}</tex-math></disp-formula></p>
      <p>If the absolute value of the difference between the average frequencies of a particular contact calculated for the two sets of trajectories is higher than a specific cut-off value, then the contact is kept as a potentially meaningful (e.g. if cutoff is set to 0.4, then only the contacts with |Δ<italic toggle="yes"><sub>freq</sub></italic>| &gt; 0.4 are kept). We visualize the average frequency differences for these meaningful interactions as red and blue sticks linking C<sub>α</sub> atoms of the interacting residues.</p>
    </sec>
    <sec id="SEC3-6">
      <title>Workflow</title>
      <p>We have created user-job pipeline with four steps and additional calculations on-the-fly while loading page or selecting elements by user. On-the-fly mode applies to initial loading of Interaction frequency analysis (HeatMaps) and to the Interaction frequency difference analysis (Sticks). By changing the contact type (hydrogen bonds, salt bridges and aromatic interactions) and/or cutoffs for HeatMaps and Sticks they are recalculated and user can check status messages (computing/done/error). Server is importing data from internal GPCRsignal database, such as PDB and PSF files, membrane thickness, and chain identifiers for receptor and each effector protein.</p>
      <p>The steps are:</p>
      <list list-type="order">
        <list-item>
          <p>Preparation phase—applying mutations to WT structure and preparing NAMD input files.</p>
        </list-item>
        <list-item>
          <p>Molecular dynamics—running all-atom MD simulation in implicit environments.</p>
        </list-item>
        <list-item>
          <p>Plotting—running get_contacts scripts (computing for displaying results and pre-computing as much as possible for on-the-fly computations).</p>
        </list-item>
        <list-item>
          <p>Finishing – creating archives, copying working files to results directory, sending e-mail with job status.</p>
        </list-item>
      </list>
    </sec>
  </sec>
  <sec sec-type="results" id="SEC4">
    <title>RESULTS</title>
    <sec id="SEC4-1">
      <title>Description of input</title>
      <p>User can browse through a table of curated structures of GPCR-effector protein (G protein or arrestin) complexes. After selecting a structure, the user can go into details of the complex presenting structure and descriptions on several tiles (Figure <xref rid="F2" ref-type="fig">2A</xref>,B) or go to the MD&amp;mutation preparation page (Figure <xref rid="F2" ref-type="fig">2C</xref>).</p>
      <p>In the MD&amp;mutation page the Mutations mode (Figure <xref rid="F2" ref-type="fig">2C</xref>) has to be selected: (i) with crystal/cryo-EM structure mutations, (ii) WT or (iii) WT with user defined mutations. There is no maximal number of user mutations. Then, parameters of simulations are to be specified or their default values used: (i) total length of a simulation: default = 10 ns, min = 5 ns, max = 25 ns; (ii) number of frames in a simulation: default = 100, min = 5, max = 200; and (iii) the membrane thickness: default value is taken from internal database (based on value for particular receptor in OPM database (<xref rid="B37" ref-type="bibr">37</xref>) ), min = 20 Å, max = 40 Å. All the above selections must be confirmed by the user after pushing ‘Start MD’ button. On the confirmation page, there is also a possibility to add a job description and e-mail for receiving notification of job completion.</p>
    </sec>
    <sec id="SEC4-2">
      <title>Description of output</title>
      <p>After completion of the MD simulation a new page starts with analysis of single trajectory. On that page one can select type of contact, e.g. hydrogen bonds, and the FlarePlot can visualize contacts in the interface between receptor and effector protein for the single frame (Figure <xref rid="F3" ref-type="fig">3A</xref>), range of frames (Figure <xref rid="F3" ref-type="fig">3B</xref>). The structure of the complex (Figure <xref rid="F3" ref-type="fig">3C</xref>) is changing as the simulation is playing and it refers to a particular frame or the first frame if a range of frames is selected. A variety of options for displaying a structure are available (Figure <xref rid="F3" ref-type="fig">3D</xref>).</p>
      <fig position="float" id="F3">
        <label>Figure 3.</label>
        <caption>
          <p>Analysis of a single trajectory. (<bold>A</bold>) FlarePlot showing contacts in the interface between receptor (purple color) and effector protein (G<sub>α</sub>—green, G<sub>β</sub>—yellow, G<sub>γ</sub>—orange) for the single frame. (<bold>B</bold>) The same for range of frames. (<bold>C</bold>) The structure of the complex with blue and red transparent squares visualizing the edges of the membrane. (<bold>D</bold>) The menu for displaying a complex structure. The color mode GPCRsignal is the same as shown in panel (C).</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="gkab434fig3" position="float"/>
      </fig>
      <p>Analysis of multiple MDs starts from selecting of completed simulations by copying their tokens into a table on ‘Comparison of multiple MDs’ page. The computed trajectories are stored on the server for two months. Comparison of trajectories can be done via Interaction frequency analysis on HeatMaps (Figure <xref rid="F4" ref-type="fig">4A</xref>) and via the Interaction frequency difference analysis (Figure <xref rid="F4" ref-type="fig">4B</xref>). In both cases, the specific cutoffs can be set up to exclude the smallest contact frequencies. For the latter analysis, the interaction frequency difference is visualized via sticks linking interacting residues (their C<sub>α</sub> atoms) with blue and red color meaning positive or negative difference in contact frequencies. Since the simulations start each time with different set of atom velocities the final structures and resulting contacts can be different even for the same initial complex structure as this is a statistical process. Therefore, a series of shorter simulations with later averaging is preferred over one longer simulation.</p>
      <fig position="float" id="F4">
        <label>Figure 4.</label>
        <caption>
          <p>(<bold>A</bold>) Interaction frequency analysis on HeatMaps. A scale bar shows percentage of frequencies. A cutoff excludes the smallest contact frequencies. The first two simulations are for WT, while two others for mutated structure. (<bold>B</bold>) Interaction frequency difference analysis for selected two groups of simulations denoted A and B. Here, group A is for WT simulations and B for simulations with mutated structure. The sticks linking C<sub>α</sub> atoms of interacting residues are colored in red and blue meaning positive or negative difference in contact frequencies, respectively. The size of sticks and color intensity are proportional to particular contact frequency difference and is visualized on a scale hourglass. As before, the cutoff excludes the smallest differences in contact frequencies.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="gkab434fig4" position="float"/>
      </fig>
      <p>One can download a package with results for each task. It is a ZIP file including basic files: protein structure (format PDB/PSF), result of molecular dynamics (format DCD), job information file (text file), contacts files (format: tab-separated values) and Flareplot files (format json). Protein files are ready to use with corresponding DCD file if user want to visualize simulation in external visualization software. Protein results files depend on selected wild-type or crystal/cryo-EM structure mode, and include user applied mutations if they were used. From the job information file, one can take the job parameters or take a link to results to visualize those results on GPCRsignal server and make analyses (if within 2 months).</p>
      <p>For the contacts, we supply file describing all contacts between receptor and effector proteins in simulation, and type-separated contact frequencies files. Flareplots could be generated by uploading those json files on the page: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://gpcrviz.github.io/flareplot/?p=create" ext-link-type="uri">https://gpcrviz.github.io/flareplot/?p=create</ext-link>. It is useful when one needs to display results after 2 months (when data will be removed from our server) or when user want to make any changes to circular plot.</p>
      <p>There is a possibility to share the selected MD simulations with other users. This can be done with a button ‘Make this job available to public’ on the results page (accessible just after the simulation is completed or later with the simulation token). The shared simulations are visible via menu item ‘Shared jobs’. The shared data can be analyzed as single trajectories or groups of simulations via ‘Comparison’ page.</p>
    </sec>
    <sec id="SEC4-3">
      <title>Performance and comparison to all-atom explicit system</title>
      <p>MD simulation of 25 ns for CB<sub>1</sub> receptor with trimeric G protein (PDB ID: 6KPG), with number of atoms and united atoms in CHARMM19 force field about 8700, takes about 6 h. For comparison, 25 ns MD simulation of the same system in full POPC membrane and water, containing about 120 000 atoms, takes about 120 h (5 days) on the same server.</p>
      <p>We compared RMSD (root-mean-square deviation) plots for exemplary complex PDB ID: 6KPG simulated in explicit (EE) and implicit (IE) environments (Figure <xref rid="F5" ref-type="fig">5</xref>). RMSD values were calculated for C<sub>α</sub> atoms of the whole complex. For the WT complex simulated in EE the structure stabilized at 2 Å in one MD simulation but at 3 Å in the second simulation (Figure <xref rid="F5" ref-type="fig">5A</xref>) while it reached 4 and 4.5 Å in IE (Figure <xref rid="F5" ref-type="fig">5B</xref>). For the mutated complex simulated in EE, the structure stabilized at about 2.5 Å in both simulations (Figure <xref rid="F6" ref-type="fig">6A</xref>) and in IE at 4 Å (Figure <xref rid="F6" ref-type="fig">6B</xref>). For the mutated structure, we selected a set of disruptive mutations: R:R145A, R:R226A, A:D350A and A:F354A, where the first letter denotes a chain: R for receptor and A for G<sub>α</sub> subunit. Such mutations disrupted salt bridges and stacking interactions but MD simulations conducted both in EE and IE show that the overall structure of the complex is still very stable. Local changes can be visualized using FlarePlots and HeatMaps in our server. Higher values of RMSD plots obtained in IE are a consequence of higher flexibility of the complex in implicit environments. Length of 25 ns of MD simulation seems to be adequate to obtain stability of complex structure, however, to compare the immediate effects of mutations much smaller MD simulations can be applied.</p>
      <fig position="float" id="F5">
        <label>Figure 5.</label>
        <caption>
          <p>RMSD plots for the same exemplary wild-type (WT) CB<sub>1</sub>-G<sub>i(αβγ)</sub> complex (PDB id:6KPG) simulated in explicit (<bold>A</bold>) and implicit (<bold>B</bold>) environments.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="gkab434fig5" position="float"/>
      </fig>
      <fig position="float" id="F6">
        <label>Figure 6.</label>
        <caption>
          <p>RMSD plots for the same exemplary CB<sub>1</sub>-G<sub>i(αβγ)</sub> complex (PDB ID: 6KPG) with four user defined mutations (4 mut) simulated in explicit (<bold>A</bold>) and implicit (<bold>B</bold>) environments.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="gkab434fig6" position="float"/>
      </fig>
    </sec>
    <sec id="SEC4-4">
      <title>Tutorial</title>
      <p>The extensive tutorial starts from a slide show showing the GPCR signaling cycle which could be useful for students and also researchers not working routinely with GPCRs. Then, each page of the web server is described with all available options. The example output is also shown for analysis of single MD simulation (menu: Example 1) and for analysis of multiple MD simulations (menu: Example 2). All types of performed analyses are described and especially those for groups of simulations: the interaction frequency analysis (HeatMaps) and the interaction frequency difference analysis (Sticks).</p>
    </sec>
  </sec>
  <sec sec-type="conclusions" id="SEC5">
    <title>CONCLUSION</title>
    <p>The GPCRsignal web server is intended to be used for analyses of the interface between GPCRs and their effector proteins: G proteins and arrestins. The analyses are performed in a dynamic way by MD simulations and mutations and they can be useful for researchers and students interested in GPCR signaling processes. Currently, there are about 100 structures of GPCR-effector protein complexes in the Protein Data Bank but due to enormous progress in experimental determination of such complexes we can expect a large number of such structures which will greatly facilitate research on biased signaling.</p>
  </sec>
  <sec sec-type="data-availability" id="SEC6">
    <title>DATA AVAILABILITY</title>
    <p>GPCRsignal is free to all users without a login requirement. The e-mail is optional (for receiving notification of job completion) and is not stored on the server.</p>
  </sec>
</body>
<back>
  <ack id="ACK1">
    <title>ACKNOWLEDGEMENTS</title>
    <p>The European COST Action CA18133 (ERNEST) is acknowledged for providing biannual forum for exchange of ideas on GPCR research and for supporting mutual visits.</p>
  </ack>
  <sec id="SEC7">
    <title>FUNDING</title>
    <p>National Science Centre [OPUS 2017/25/B/NZ7/02788 to S.F.]. Funding for open access charge: National Science Centre [OPUS 2017/25/B/NZ7/02788 to S.F.].</p>
    <p><italic toggle="yes">Conflict of interest statement</italic>. None declared.</p>
  </sec>
  <ref-list id="REF1">
    <title>REFERENCES</title>
    <ref id="B1">
      <label>1.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rockman</surname><given-names>H.A.</given-names></string-name>, <string-name><surname>Koch</surname><given-names>W.J.</given-names></string-name>, <string-name><surname>Lefkowitz</surname><given-names>R.J.</given-names></string-name></person-group><article-title>Seven-transmembrane-spanning receptors and heart function</article-title>. <source>Nature</source>. <year>2002</year>; <volume>415</volume>:<fpage>206</fpage>–<lpage>212</lpage>.<pub-id pub-id-type="pmid">11805844</pub-id></mixed-citation>
    </ref>
    <ref id="B2">
      <label>2.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hilger</surname><given-names>D.</given-names></string-name>, <string-name><surname>Masureel</surname><given-names>M.</given-names></string-name>, <string-name><surname>Kobilka</surname><given-names>B.K.</given-names></string-name></person-group><article-title>Structure and dynamics of GPCR signaling complexes</article-title>. <source>Nat. Struct. Mol. Biol.</source><year>2018</year>; <volume>25</volume>:<fpage>4</fpage>–<lpage>12</lpage>.<pub-id pub-id-type="pmid">29323277</pub-id></mixed-citation>
    </ref>
    <ref id="B3">
      <label>3.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hauser</surname><given-names>A.S.</given-names></string-name>, <string-name><surname>Attwood</surname><given-names>M.M.</given-names></string-name>, <string-name><surname>Rask-Andersen</surname><given-names>M.</given-names></string-name>, <string-name><surname>Schioth</surname><given-names>H.B.</given-names></string-name>, <string-name><surname>Gloriam</surname><given-names>D.E.</given-names></string-name></person-group><article-title>Trends in GPCR drug discovery: new agents, targets and indications</article-title>. <source>Nat. Rev. Drug Discov.</source><year>2017</year>; <volume>16</volume>:<fpage>829</fpage>–<lpage>842</lpage>.<pub-id pub-id-type="pmid">29075003</pub-id></mixed-citation>
    </ref>
    <ref id="B4">
      <label>4.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fredriksson</surname><given-names>R.</given-names></string-name>, <string-name><surname>Lagerstrom</surname><given-names>M.C.</given-names></string-name>, <string-name><surname>Lundin</surname><given-names>L.G.</given-names></string-name>, <string-name><surname>Schioth</surname><given-names>H.B.</given-names></string-name></person-group><article-title>The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints</article-title>. <source>Mol. Pharmacol.</source><year>2003</year>; <volume>63</volume>:<fpage>1256</fpage>–<lpage>1272</lpage>.<pub-id pub-id-type="pmid">12761335</pub-id></mixed-citation>
    </ref>
    <ref id="B5">
      <label>5.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nordstrom</surname><given-names>K.J.</given-names></string-name>, <string-name><surname>Sallman Almen</surname><given-names>M.</given-names></string-name>, <string-name><surname>Edstam</surname><given-names>M.M.</given-names></string-name>, <string-name><surname>Fredriksson</surname><given-names>R.</given-names></string-name>, <string-name><surname>Schioth</surname><given-names>H.B.</given-names></string-name></person-group><article-title>Independent HHsearch, Needleman–Wunsch-based, and motif analyses reveal the overall hierarchy for most of the G protein-coupled receptor families</article-title>. <source>Mol. Biol. Evol.</source><year>2011</year>; <volume>28</volume>:<fpage>2471</fpage>–<lpage>2480</lpage>.<pub-id pub-id-type="pmid">21402729</pub-id></mixed-citation>
    </ref>
    <ref id="B6">
      <label>6.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gurevich</surname><given-names>V.V.</given-names></string-name>, <string-name><surname>Gurevich</surname><given-names>E.V.</given-names></string-name></person-group><article-title>GPCR signaling regulation: the role of GRKs and arrestins</article-title>. <source>Front. Pharmacol.</source><year>2019</year>; <volume>10</volume>:<fpage>125</fpage>.<pub-id pub-id-type="pmid">30837883</pub-id></mixed-citation>
    </ref>
    <ref id="B7">
      <label>7.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Seyedabadi</surname><given-names>M.</given-names></string-name>, <string-name><surname>Gharghabi</surname><given-names>M.</given-names></string-name>, <string-name><surname>Gurevich</surname><given-names>E.V.</given-names></string-name>, <string-name><surname>Gurevich</surname><given-names>V.V.</given-names></string-name></person-group><article-title>Receptor-arrestin interactions: the GPCR perspective</article-title>. <source>Biomolecules</source>. <year>2021</year>; <volume>11</volume>:<fpage>218</fpage>.<pub-id pub-id-type="pmid">33557162</pub-id></mixed-citation>
    </ref>
    <ref id="B8">
      <label>8.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sutkeviciute</surname><given-names>I.</given-names></string-name>, <string-name><surname>Vilardaga</surname><given-names>J.P.</given-names></string-name></person-group><article-title>Structural insights into emergent signaling modes of G protein-coupled receptors</article-title>. <source>J. Biol. Chem.</source><year>2020</year>; <volume>295</volume>:<fpage>11626</fpage>–<lpage>11642</lpage>.<pub-id pub-id-type="pmid">32571882</pub-id></mixed-citation>
    </ref>
    <ref id="B9">
      <label>9.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kenakin</surname><given-names>T.</given-names></string-name></person-group><article-title>Biased receptor signaling in drug discovery</article-title>. <source>Pharmacol. Rev.</source><year>2019</year>; <volume>71</volume>:<fpage>267</fpage>–<lpage>315</lpage>.<pub-id pub-id-type="pmid">30914442</pub-id></mixed-citation>
    </ref>
    <ref id="B10">
      <label>10.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Smith</surname><given-names>J.S.</given-names></string-name>, <string-name><surname>Lefkowitz</surname><given-names>R.J.</given-names></string-name>, <string-name><surname>Rajagopal</surname><given-names>S.</given-names></string-name></person-group><article-title>Biased signalling: from simple switches to allosteric microprocessors</article-title>. <source>Nat. Rev. Drug Discov.</source><year>2018</year>; <volume>17</volume>:<fpage>243</fpage>–<lpage>260</lpage>.<pub-id pub-id-type="pmid">29302067</pub-id></mixed-citation>
    </ref>
    <ref id="B11">
      <label>11.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bock</surname><given-names>A.</given-names></string-name>, <string-name><surname>Bermudez</surname><given-names>M.</given-names></string-name></person-group><article-title>Allosteric coupling and biased agonism in G protein-coupled receptors</article-title>. <source>FEBS J.</source><year>2021</year>; <volume>288</volume>:<fpage>2513</fpage>–<lpage>2528</lpage>.<pub-id pub-id-type="pmid">33621418</pub-id></mixed-citation>
    </ref>
    <ref id="B12">
      <label>12.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Erlandson</surname><given-names>S.C.</given-names></string-name>, <string-name><surname>McMahon</surname><given-names>C.</given-names></string-name>, <string-name><surname>Kruse</surname><given-names>A.C.</given-names></string-name></person-group><article-title>Structural basis for G protein-coupled receptor signaling</article-title>. <source>Annu. Rev. Biophys.</source><year>2018</year>; <volume>47</volume>:<fpage>1</fpage>–<lpage>18</lpage>.<pub-id pub-id-type="pmid">29498889</pub-id></mixed-citation>
    </ref>
    <ref id="B13">
      <label>13.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Milligan</surname><given-names>G.</given-names></string-name>, <string-name><surname>Kostenis</surname><given-names>E.</given-names></string-name></person-group><article-title>Heterotrimeric G-proteins: a short history</article-title>. <source>Br. J. Pharmacol.</source><year>2006</year>; <volume>147</volume>(<issue>Suppl. 1</issue>):<fpage>S46</fpage>–<lpage>S55</lpage>.<pub-id pub-id-type="pmid">16402120</pub-id></mixed-citation>
    </ref>
    <ref id="B14">
      <label>14.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lefkowitz</surname><given-names>R.J.</given-names></string-name>, <string-name><surname>Shenoy</surname><given-names>S.K.</given-names></string-name></person-group><article-title>Transduction of receptor signals by beta-arrestins</article-title>. <source>Science</source>. <year>2005</year>; <volume>308</volume>:<fpage>512</fpage>–<lpage>517</lpage>.<pub-id pub-id-type="pmid">15845844</pub-id></mixed-citation>
    </ref>
    <ref id="B15">
      <label>15.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shukla</surname><given-names>A.K.</given-names></string-name>, <string-name><surname>Westfield</surname><given-names>G.H.</given-names></string-name>, <string-name><surname>Xiao</surname><given-names>K.</given-names></string-name>, <string-name><surname>Reis</surname><given-names>R.I.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>L.Y.</given-names></string-name>, <string-name><surname>Tripathi-Shukla</surname><given-names>P.</given-names></string-name>, <string-name><surname>Qian</surname><given-names>J.</given-names></string-name>, <string-name><surname>Li</surname><given-names>S.</given-names></string-name>, <string-name><surname>Blanc</surname><given-names>A.</given-names></string-name>, <string-name><surname>Oleskie</surname><given-names>A.N.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Visualization of arrestin recruitment by a G-protein-coupled receptor</article-title>. <source>Nature</source>. <year>2014</year>; <volume>512</volume>:<fpage>218</fpage>–<lpage>222</lpage>.<pub-id pub-id-type="pmid">25043026</pub-id></mixed-citation>
    </ref>
    <ref id="B16">
      <label>16.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Latorraca</surname><given-names>N.R.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>J.K.</given-names></string-name>, <string-name><surname>Bauer</surname><given-names>B.</given-names></string-name>, <string-name><surname>Townshend</surname><given-names>R.J.L.</given-names></string-name>, <string-name><surname>Hollingsworth</surname><given-names>S.A.</given-names></string-name>, <string-name><surname>Olivieri</surname><given-names>J.E.</given-names></string-name>, <string-name><surname>Xu</surname><given-names>H.E.</given-names></string-name>, <string-name><surname>Sommer</surname><given-names>M.E.</given-names></string-name>, <string-name><surname>Dror</surname><given-names>R.O</given-names></string-name></person-group><article-title>Molecular mechanism of GPCR-mediated arrestin activation</article-title>. <source>Nature</source>. <year>2018</year>; <volume>557</volume>:<fpage>452</fpage>–<lpage>456</lpage>.<pub-id pub-id-type="pmid">29720655</pub-id></mixed-citation>
    </ref>
    <ref id="B17">
      <label>17.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cahill</surname><given-names>T.J.</given-names><suffix>3rd</suffix></string-name>, <string-name><surname>Thomsen</surname><given-names>A.R.</given-names></string-name>, <string-name><surname>Tarrasch</surname><given-names>J.T.</given-names></string-name>, <string-name><surname>Plouffe</surname><given-names>B.</given-names></string-name>, <string-name><surname>Nguyen</surname><given-names>A.H.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>F.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>L.Y.</given-names></string-name>, <string-name><surname>Kahsai</surname><given-names>A.W.</given-names></string-name>, <string-name><surname>Bassoni</surname><given-names>D.L.</given-names></string-name>, <string-name><surname>Gavino</surname><given-names>B.J.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Distinct conformations of GPCR-beta-arrestin complexes mediate desensitization, signaling, and endocytosis</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source><year>2017</year>; <volume>114</volume>:<fpage>2562</fpage>–<lpage>2567</lpage>.<pub-id pub-id-type="pmid">28223524</pub-id></mixed-citation>
    </ref>
    <ref id="B18">
      <label>18.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Latorraca</surname><given-names>N.R.</given-names></string-name>, <string-name><surname>Masureel</surname><given-names>M.</given-names></string-name>, <string-name><surname>Hollingsworth</surname><given-names>S.A.</given-names></string-name>, <string-name><surname>Heydenreich</surname><given-names>F.M.</given-names></string-name>, <string-name><surname>Suomivuori</surname><given-names>C.M.</given-names></string-name>, <string-name><surname>Brinton</surname><given-names>C.</given-names></string-name>, <string-name><surname>Townshend</surname><given-names>R.J.L.</given-names></string-name>, <string-name><surname>Bouvier</surname><given-names>M.</given-names></string-name>, <string-name><surname>Kobilka</surname><given-names>B.K.</given-names></string-name>, <string-name><surname>Dror</surname><given-names>R.O</given-names></string-name></person-group><article-title>How GPCR phosphorylation patterns orchestrate arrestin-mediated signaling</article-title>. <source>Cell</source>. <year>2020</year>; <volume>183</volume>:<fpage>1813</fpage>–<lpage>1825</lpage>.<pub-id pub-id-type="pmid">33296703</pub-id></mixed-citation>
    </ref>
    <ref id="B19">
      <label>19.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Puca</surname><given-names>L.</given-names></string-name>, <string-name><surname>Brou</surname><given-names>C.</given-names></string-name></person-group><article-title>Alpha-arrestins - new players in Notch and GPCR signaling pathways in mammals</article-title>. <source>J. Cell Sci.</source><year>2014</year>; <volume>127</volume>:<fpage>1359</fpage>–<lpage>1367</lpage>.<pub-id pub-id-type="pmid">24687185</pub-id></mixed-citation>
    </ref>
    <ref id="B20">
      <label>20.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cherezov</surname><given-names>V.</given-names></string-name>, <string-name><surname>Rosenbaum</surname><given-names>D.M.</given-names></string-name>, <string-name><surname>Hanson</surname><given-names>M.A.</given-names></string-name>, <string-name><surname>Rasmussen</surname><given-names>S.G.</given-names></string-name>, <string-name><surname>Thian</surname><given-names>F.S.</given-names></string-name>, <string-name><surname>Kobilka</surname><given-names>T.S.</given-names></string-name>, <string-name><surname>Choi</surname><given-names>H.J.</given-names></string-name>, <string-name><surname>Kuhn</surname><given-names>P.</given-names></string-name>, <string-name><surname>Weis</surname><given-names>W.I.</given-names></string-name>, <string-name><surname>Kobilka</surname><given-names>B.K.</given-names></string-name><etal>et al</etal>.</person-group><article-title>High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor</article-title>. <source>Science</source>. <year>2007</year>; <volume>318</volume>:<fpage>1258</fpage>–<lpage>1265</lpage>.<pub-id pub-id-type="pmid">17962520</pub-id></mixed-citation>
    </ref>
    <ref id="B21">
      <label>21.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Velazhahan</surname><given-names>V.</given-names></string-name>, <string-name><surname>Ma</surname><given-names>N.</given-names></string-name>, <string-name><surname>Pandy-Szekeres</surname><given-names>G.</given-names></string-name>, <string-name><surname>Kooistra</surname><given-names>A.J.</given-names></string-name>, <string-name><surname>Lee</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Gloriam</surname><given-names>D.E.</given-names></string-name>, <string-name><surname>Vaidehi</surname><given-names>N.</given-names></string-name>, <string-name><surname>Tate</surname><given-names>C.G.</given-names></string-name></person-group><article-title>Structure of the class D GPCR Ste2 dimer coupled to two G proteins</article-title>. <source>Nature</source>. <year>2021</year>; <volume>589</volume>:<fpage>148</fpage>–<lpage>153</lpage>.<pub-id pub-id-type="pmid">33268889</pub-id></mixed-citation>
    </ref>
    <ref id="B22">
      <label>22.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liang</surname><given-names>Y.L.</given-names></string-name>, <string-name><surname>Belousoff</surname><given-names>M.J.</given-names></string-name>, <string-name><surname>Fletcher</surname><given-names>M.M.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>X.</given-names></string-name>, <string-name><surname>Khoshouei</surname><given-names>M.</given-names></string-name>, <string-name><surname>Deganutti</surname><given-names>G.</given-names></string-name>, <string-name><surname>Koole</surname><given-names>C.</given-names></string-name>, <string-name><surname>Furness</surname><given-names>S.G.B.</given-names></string-name>, <string-name><surname>Miller</surname><given-names>L.J.</given-names></string-name>, <string-name><surname>Hay</surname><given-names>D.L.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Structure and dynamics of adrenomedullin receptors AM1 and AM2 reveal key mechanisms in the control of receptor phenotype by receptor activity-modifying proteins</article-title>. <source>ACS Pharmacol. Transl. Sci.</source><year>2020</year>; <volume>3</volume>:<fpage>263</fpage>–<lpage>284</lpage>.<pub-id pub-id-type="pmid">32296767</pub-id></mixed-citation>
    </ref>
    <ref id="B23">
      <label>23.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Esguerra</surname><given-names>M.</given-names></string-name>, <string-name><surname>Siretskiy</surname><given-names>A.</given-names></string-name>, <string-name><surname>Bello</surname><given-names>X.</given-names></string-name>, <string-name><surname>Sallander</surname><given-names>J.</given-names></string-name>, <string-name><surname>Gutierrez-de-Teran</surname><given-names>H.</given-names></string-name></person-group><article-title>GPCR-ModSim: a comprehensive web based solution for modeling G-protein coupled receptors</article-title>. <source>Nucleic Acids Res.</source><year>2016</year>; <volume>44</volume>:<fpage>W455</fpage>–<lpage>W462</lpage>.<pub-id pub-id-type="pmid">27166369</pub-id></mixed-citation>
    </ref>
    <ref id="B24">
      <label>24.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Schneider</surname><given-names>J.</given-names></string-name>, <string-name><surname>Ribeiro</surname><given-names>R.</given-names></string-name>, <string-name><surname>Alfonso-Prieto</surname><given-names>M.</given-names></string-name>, <string-name><surname>Carloni</surname><given-names>P.</given-names></string-name>, <string-name><surname>Giorgetti</surname><given-names>A.</given-names></string-name></person-group><article-title>Hybrid MM/CG webserver: automatic set up of molecular mechanics/coarse-grained simulations for human G protein-coupled receptor/ligand complexes</article-title>. <source>Front. Mol. Biosci.</source><year>2020</year>; <volume>7</volume>:<fpage>576689</fpage>.<pub-id pub-id-type="pmid">33102525</pub-id></mixed-citation>
    </ref>
    <ref id="B25">
      <label>25.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sandal</surname><given-names>M.</given-names></string-name>, <string-name><surname>Duy</surname><given-names>T.P.</given-names></string-name>, <string-name><surname>Cona</surname><given-names>M.</given-names></string-name>, <string-name><surname>Zung</surname><given-names>H.</given-names></string-name>, <string-name><surname>Carloni</surname><given-names>P.</given-names></string-name>, <string-name><surname>Musiani</surname><given-names>F.</given-names></string-name>, <string-name><surname>Giorgetti</surname><given-names>A.</given-names></string-name></person-group><article-title>GOMoDo: a GPCRs online modeling and docking webserver</article-title>. <source>PLoS One</source>. <year>2013</year>; <volume>8</volume>:<fpage>e74092</fpage>.<pub-id pub-id-type="pmid">24058518</pub-id></mixed-citation>
    </ref>
    <ref id="B26">
      <label>26.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kooistra</surname><given-names>A.J.</given-names></string-name>, <string-name><surname>Mordalski</surname><given-names>S.</given-names></string-name>, <string-name><surname>Pandy-Szekeres</surname><given-names>G.</given-names></string-name>, <string-name><surname>Esguerra</surname><given-names>M.</given-names></string-name>, <string-name><surname>Mamyrbekov</surname><given-names>A.</given-names></string-name>, <string-name><surname>Munk</surname><given-names>C.</given-names></string-name>, <string-name><surname>Keseru</surname><given-names>G.M.</given-names></string-name>, <string-name><surname>Gloriam</surname><given-names>D.E.</given-names></string-name></person-group><article-title>GPCRdb in 2021: integrating GPCR sequence, structure and function</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>; <volume>49</volume>:<fpage>D335</fpage>–<lpage>D343</lpage>.<pub-id pub-id-type="pmid">33270898</pub-id></mixed-citation>
    </ref>
    <ref id="B27">
      <label>27.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rodriguez-Espigares</surname><given-names>I.</given-names></string-name>, <string-name><surname>Torrens-Fontanals</surname><given-names>M.</given-names></string-name>, <string-name><surname>Tiemann</surname><given-names>J.K.S.</given-names></string-name>, <string-name><surname>Aranda-Garcia</surname><given-names>D.</given-names></string-name>, <string-name><surname>Ramirez-Anguita</surname><given-names>J.M.</given-names></string-name>, <string-name><surname>Stepniewski</surname><given-names>T.M.</given-names></string-name>, <string-name><surname>Worp</surname><given-names>N.</given-names></string-name>, <string-name><surname>Varela-Rial</surname><given-names>A.</given-names></string-name>, <string-name><surname>Morales-Pastor</surname><given-names>A.</given-names></string-name>, <string-name><surname>Medel-Lacruz</surname><given-names>B.</given-names></string-name><etal>et al</etal>.</person-group><article-title>GPCRmd uncovers the dynamics of the 3D-GPCRome</article-title>. <source>Nat. Methods</source>. <year>2020</year>; <volume>17</volume>:<fpage>777</fpage>–<lpage>787</lpage>.<pub-id pub-id-type="pmid">32661425</pub-id></mixed-citation>
    </ref>
    <ref id="B28">
      <label>28.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sehnal</surname><given-names>D.</given-names></string-name>, <string-name><surname>Bittrich</surname><given-names>S.</given-names></string-name>, <string-name><surname>Deshpande</surname><given-names>M.</given-names></string-name>, <string-name><surname>Svobodova</surname><given-names>R.</given-names></string-name>, <string-name><surname>Berka</surname><given-names>K.</given-names></string-name>, <string-name><surname>Bazgier</surname><given-names>V.</given-names></string-name>, <string-name><surname>Velankar</surname><given-names>S.</given-names></string-name>, <string-name><surname>Burley</surname><given-names>S.K.</given-names></string-name>, <string-name><surname>Koca</surname><given-names>J.</given-names></string-name>, <string-name><surname>Rose</surname><given-names>A.S.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Mol* Viewer: modern web app for 3D visualization and analysis of large biomolecular structures</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>; <pub-id pub-id-type="doi">10.1093/nar/gkab314</pub-id>.</mixed-citation>
    </ref>
    <ref id="B29">
      <label>29.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hoksza</surname><given-names>D.</given-names></string-name>, <string-name><surname>Gawron</surname><given-names>P.</given-names></string-name>, <string-name><surname>Ostaszewski</surname><given-names>M.</given-names></string-name>, <string-name><surname>Schneider</surname><given-names>R.</given-names></string-name></person-group><article-title>MolArt: a molecular structure annotation and visualization tool</article-title>. <source>Bioinformatics</source>. <year>2018</year>; <volume>34</volume>:<fpage>4127</fpage>–<lpage>4128</lpage>.<pub-id pub-id-type="pmid">29931246</pub-id></mixed-citation>
    </ref>
    <ref id="B30">
      <label>30.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rose</surname><given-names>A.S.</given-names></string-name>, <string-name><surname>Hildebrand</surname><given-names>P.W.</given-names></string-name></person-group><article-title>NGL Viewer: a web application for molecular visualization</article-title>. <source>Nucleic Acids Res.</source><year>2015</year>; <volume>43</volume>:<fpage>W576</fpage>–<lpage>W579</lpage>.<pub-id pub-id-type="pmid">25925569</pub-id></mixed-citation>
    </ref>
    <ref id="B31">
      <label>31.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rose</surname><given-names>A.S.</given-names></string-name>, <string-name><surname>Bradley</surname><given-names>A.R.</given-names></string-name>, <string-name><surname>Valasatava</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Duarte</surname><given-names>J.M.</given-names></string-name>, <string-name><surname>Prlic</surname><given-names>A.</given-names></string-name>, <string-name><surname>Rose</surname><given-names>P.W.</given-names></string-name></person-group><article-title>NGL viewer: web-based molecular graphics for large complexes</article-title>. <source>Bioinformatics</source>. <year>2018</year>; <volume>34</volume>:<fpage>3755</fpage>–<lpage>3758</lpage>.<pub-id pub-id-type="pmid">29850778</pub-id></mixed-citation>
    </ref>
    <ref id="B32">
      <label>32.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lazaridis</surname><given-names>T.</given-names></string-name></person-group><article-title>Effective energy function for proteins in lipid membranes</article-title>. <source>Proteins</source>. <year>2003</year>; <volume>52</volume>:<fpage>176</fpage>–<lpage>192</lpage>.<pub-id pub-id-type="pmid">12833542</pub-id></mixed-citation>
    </ref>
    <ref id="B33">
      <label>33.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Phillips</surname><given-names>J.C.</given-names></string-name>, <string-name><surname>Hardy</surname><given-names>D.J.</given-names></string-name>, <string-name><surname>Maia</surname><given-names>J.D.C.</given-names></string-name>, <string-name><surname>Stone</surname><given-names>J.E.</given-names></string-name>, <string-name><surname>Ribeiro</surname><given-names>J.V.</given-names></string-name>, <string-name><surname>Bernardi</surname><given-names>R.C.</given-names></string-name>, <string-name><surname>Buch</surname><given-names>R.</given-names></string-name>, <string-name><surname>Fiorin</surname><given-names>G.</given-names></string-name>, <string-name><surname>Henin</surname><given-names>J.</given-names></string-name>, <string-name><surname>Jiang</surname><given-names>W.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Scalable molecular dynamics on CPU and GPU architectures with NAMD</article-title>. <source>J. Chem. Phys.</source><year>2020</year>; <volume>153</volume>:<fpage>044130</fpage>.<pub-id pub-id-type="pmid">32752662</pub-id></mixed-citation>
    </ref>
    <ref id="B34">
      <label>34.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lazaridis</surname><given-names>T.</given-names></string-name>, <string-name><surname>Karplus</surname><given-names>M.</given-names></string-name></person-group><article-title>Effective energy function for proteins in solution</article-title>. <source>Proteins</source>. <year>1999</year>; <volume>35</volume>:<fpage>133</fpage>–<lpage>152</lpage>.<pub-id pub-id-type="pmid">10223287</pub-id></mixed-citation>
    </ref>
    <ref id="B35">
      <label>35.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ryckaert</surname><given-names>J.-P.C.</given-names></string-name>, <string-name><surname>Berendsen</surname><given-names>H.J.C</given-names></string-name></person-group><article-title>Numerical integration of the cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes</article-title>. <source>J. Comput. Phys.</source><year>1977</year>; <volume>23</volume>:<fpage>327</fpage>–<lpage>341</lpage>.</mixed-citation>
    </ref>
    <ref id="B36">
      <label>36.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Brooks</surname><given-names>B.R.</given-names></string-name>, <string-name><surname>Brooks</surname><given-names>C.L.</given-names><suffix>3rd</suffix></string-name>, <string-name><surname>Mackerell</surname><given-names>A.D.</given-names><suffix>Jr</suffix></string-name>, <string-name><surname>Nilsson</surname><given-names>L.</given-names></string-name>, <string-name><surname>Petrella</surname><given-names>R.J.</given-names></string-name>, <string-name><surname>Roux</surname><given-names>B.</given-names></string-name>, <string-name><surname>Won</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Archontis</surname><given-names>G.</given-names></string-name>, <string-name><surname>Bartels</surname><given-names>C.</given-names></string-name>, <string-name><surname>Boresch</surname><given-names>S.</given-names></string-name><etal>et al</etal>.</person-group><article-title>CHARMM: the biomolecular simulation program</article-title>. <source>J. Comput. Chem.</source><year>2009</year>; <volume>30</volume>:<fpage>1545</fpage>–<lpage>1614</lpage>.<pub-id pub-id-type="pmid">19444816</pub-id></mixed-citation>
    </ref>
    <ref id="B37">
      <label>37.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lomize</surname><given-names>M.A.</given-names></string-name>, <string-name><surname>Pogozheva</surname><given-names>I.D.</given-names></string-name>, <string-name><surname>Joo</surname><given-names>H.</given-names></string-name>, <string-name><surname>Mosberg</surname><given-names>H.I.</given-names></string-name>, <string-name><surname>Lomize</surname><given-names>A.L.</given-names></string-name></person-group><article-title>OPM database and PPM web server: resources for positioning of proteins in membranes</article-title>. <source>Nucleic Acids Res.</source><year>2012</year>; <volume>40</volume>:<fpage>D370</fpage>–<lpage>D376</lpage>.<pub-id pub-id-type="pmid">21890895</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
